US20100217136A1 - Medical devices - Google Patents
Medical devices Download PDFInfo
- Publication number
- US20100217136A1 US20100217136A1 US12/711,161 US71116110A US2010217136A1 US 20100217136 A1 US20100217136 A1 US 20100217136A1 US 71116110 A US71116110 A US 71116110A US 2010217136 A1 US2010217136 A1 US 2010217136A1
- Authority
- US
- United States
- Prior art keywords
- data
- sensors
- implantable
- remote device
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6867—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive specially adapted to be attached or implanted in a specific body part
- A61B5/6876—Blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0031—Implanted circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/076—Permanent implantations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6862—Stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0214—Operational features of power management of power generation or supply
- A61B2560/0219—Operational features of power management of power generation or supply of externally powered implanted units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B7/00—Instruments for auscultation
- A61B7/005—Detecting noise caused by implants, e.g. cardiac valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0001—Means for transferring electromagnetic energy to implants
- A61F2250/0002—Means for transferring electromagnetic energy to implants for data transfer
Definitions
- This invention relates to medical devices and systems that incorporate said medical devices, with particular, but by no means exclusive, reference to heart valve devices, vascular grafts, stents and other implantable devices.
- Heart valves are well known medical devices which are intended to replicate the function of the valves of the human heart, i.e., to regulate the flow of blood into or out of the chambers of the heart.
- Known heart valves can be categorised into two main types, namely mechanical heart valves and tissue heart valves.
- mechanical valves the entire valve is constructed from non-biological material, which may be a synthetic or man-made material. They may comprise a tilting disc or occluder or incorporate a bileaflet design.
- Many mechanical valves, both occluders or bileaflet are made, for example, from pyrolytic carbon.
- the disc or leaflets may be housed in a ring of titanium, for example, and coated with pyrolytic carbon.
- tissue valves usually have a sewing cuff to aid the surgeon's implantation of these devices. They are usually made of a surgical cloth, either Dacron® or Teflon.
- tissue valves are fabricated, at least in part, using tissue obtained from a suitable living source. This tissue is treated, particularly chemically, to prevent degeneration, to reduce antigenicity and to extend shelf life of the valves as well as to strengthen them.
- the tissue element uses porcine (pig) aortic valves with part of the aortic artery wall.
- porcine valve leaflets are a part of the integral functioning valve.
- Some tissue valves are fabricated from pericardial pieces, fashioned by shaping the pericardial tissue into artificial leaflets.
- the pericardium is part of the membrane surrounding the heart.
- the majority of tissue valves are made from porcine aortic valves. They may be used after trimming etc, by themselves (freesewn valves or roots) or may be sutured into a synthetic frame (stented tissue valves). Plastic mono or homopolymers are examples of such frame materials.
- These stented or framed bioprosthetic tissue valves frequently have a sewing cuff added to ease implantation, similar to mechanical valves.
- These cuffs may be made of surgical cloth, e.g., Dacron® or Teflon® and may incorporate a cloth filler, e.g. Dacron®. Some sewing cuffs on these valves are made from pericardium.
- tissue valves can be categorised into two sub-sections. More specifically, stented tissue valves utilise a stent support for the tissue valve wall whereas, in contrast, stentless tissue valves do not utilise supports of this type for the tissue valve wall, and require extra layers of sutures in order to provide a usable product. It is generally recognised that stentless (also known as free sewn or free-stent) tissue valves provide better haemodynamic performance, but suffer from the disadvantages of being rather difficult to implant and difficult to size properly.
- heart valves The use of heart valves is widespread, with more than 180,000 heart valve operations being performed every year in the western world alone. It is likely that the annual number of heart operations will increase still further in the future.
- problems associated with known heart valve devices Firstly, there is a need to monitor patients who have had heart valves fitted. At present, this postoperative monitoring process may be inconvenient, resource intensive, and expensive. In particular, monitoring is most efficaciously performed through echocardiography, which requires the provision of expensive ultrasound equipment and suitably skilled staff to perform studies and interpret results. Necessarily, such resources are only maintained at relatively large institutions such as hospitals, and thus require patients to travel (possibly over long distances) to attend a check up, which may be inconvenient.
- a related problem is that access to echocardiography monitoring is limited. In fact, it is the case that implanted heart valve dysfunction associated with abnormal valve action caused by complications such as thrombosis formation or tissue ingrowth tends to develop over a period of several weeks. This period can occur between the initial monitoring by echocardiography and further physical examinations. Additionally, it would be highly desirable to obtain feedback on the clinical performance of a heart valve over a period of time.
- there is currently no readily available method for performing an in vivo assessment of this type which is not invasive or minimally invasive, or indeed avoids patients and clinicians waiting for appointments for full assessment to be performed. It is also not easy and somewhat subjective to compare one study with another or to evaluate the gradual changes over a period of time.
- 6,409,675 disclose apparatus which are implanted into the vascular system of an individual and which are capable of providing information relating to clinically important parameters.
- the apparatus disclosed does not relate to heart valves and in particular to either valve replacement, either mechanical or tissue, or indeed to assessing the results of surgical invasive or minimally invasive procedures to repair or treat indigenous valve disorders or problems.
- the present invention addresses the above named problems, and, in particular, provides a straightforward, efficacious and economic means of obtaining clinically and physiologically useful in vivo data relevant to a patient.
- data include the condition of a heart valve implant or repair or other indigenous valve treatment, and the performance of the heart valve.
- the in vivo data can be easily obtained on a regular basis over an extended time frame. Further, data can be obtained without requiring the attention of skilled operatives so as to provide the attendant clinical staff with an assessment of any changes, either acute or chronic, occurring since the time of implant or treatment, such as changes in valve, stent or graft performance.
- patient and “body” as used herein includes both humans and animals within its scope.
- a medical device for implantation in a body comprising:
- one or more sensors for sensing a physiologically or clinically relevant parameter
- telemetric communication means for telemetrically transmitting data related to a parameter sensed by the one or more sensors to a remote device.
- a medical device adapted to be implanted in the heart of a patient and operable therein i) as a heart valve; or ii) to assist in the functioning of one of the patient's heart valves; or iii) to monitor the functioning of one of the patient's heart valves; the device comprising: one or more sensors for sensing a physiologically or clinically relevant parameter; and telemetric communication means for telemetrically transmitting data related to a parameter sensed by the one or more sensors to a remote device.
- the medical device is a heart valve which may further comprise a valve for regulating the flow of blood through the device.
- the valve comprises a number of leaflets, although this is not a limiting feature of the invention.
- the medical device may comprise a heart valve repair device.
- the heart valve repair device may comprise a heart valve support structure, such as an annular support structure. Such annular structures may be sewn onto a patient's dysfunctional heart valve.
- the medical device may comprise a structure suitable for placement in or on a patient's heart valve.
- the patient's heart valve may be a treated indigenous valve or a valve which, although untreated, might require monitoring to determine when or if future treatment or replacement is required.
- the medical device further comprises a support structure to which the one or more sensors and telemetric communication means are coupled.
- the support structure may be a graft, such as a vascular graft.
- a non-limiting example of a vascular graft is an Abdominal Aortic Aneurysm (AAA) graft.
- the support structure may comprise a stent.
- stents include coronary stents and vascular stents.
- the stents may be employed in blood vessels, such as the peripheral vascular tree, or the aorta, for example. It should be noted that vascular grafts may be employed with or without stents.
- DES Drug Elutant Stents which release an anti-thrombogenic drug
- the sensors and telemetric communication means may be located on the inside or the outside of a stent or a graft. Alternatively, the sensors may be located on the inside and the telemetric communication means on the outside or vice versa.
- the device may further comprise extension means disposed on an external surface of the vascular graft and operable so as to extend therefrom; in which at least one of the telemetric communication means and the one or more sensors is disposed on the extension means.
- the extension means can be stored in an unextended form, the unextended form being used for introduction of the graft into a body. Once implanted in the body, the extension means can be extended from the vascular graft. In embodiments in which the vascular graft is inserted using a balloon catheter, it is preferred that the extension of the extension means is achieved by way of expansion of the balloon.
- the extension means can be, for example, a wire, wire structure, fibre or fibre structure which may be raised on the surface of the vascular graft once the catheter balloon is inflated.
- the one or more sensors and telemetric communications means are disposed on an interior or an exterior surface of a vascular graft or stent.
- the device is an implant.
- the implant may be attached to a desired body part by suitable means, such as by suture or adhesive.
- the medical device is in a form suitable for injection into a body.
- a form suitable for injection into a body means that the device is at least capable of being introduced into a body in a clinically acceptable manner, for example, via an endoscope. It may be possible to provide a medical device suitable for injection using smaller injection means, such as a hypodermic needle.
- the medical device is an artificial heart or a left ventricular support device (LVad).
- LVad left ventricular support device
- Such devices contain artificial heart valves. It is possible for the sensors and telemetric communication means to be disposed on the artificial heart valves, or, alternatively, the sensors and telemetric communication means may be disposed elsewhere within or on the device.
- the telemetric communication means is a passive device.
- the device may be powered by energy transmitted by a remote device, in which instance the telemetric communication means may be a transponder, such as an RF tag device, or Radio Frequency Identification (RFID) device.
- RFID Radio Frequency Identification
- the medical device may further comprise a capacitor and means for receiving an externally applied source of energy and charging said capacitor using the externally applied source of energy, in which the telemetric communication means and/or a sensor is powered by charge stored in the capacitor.
- an external radio frequency source can be used to charge a capacitor which would gradually discharge and power up the telemetric communication means and/or a sensor.
- the commencement of the powering of the telemetric communication means and/or a sensor by the capacitor can be controlled by control means.
- the control means causes the capacitor to be discharged at desired junctures, which may be at pre-determined times, or when the control means receives a control signal delivered from a device external to the body, such as an appropriate radio frequency signal.
- the telemetric communication means may be powered by an energy source disposed on or in physical connection with the medical device, such as a battery.
- the medical device may further comprise a capacitor and means for charging said capacitor using energy associated with a physiological event, in which the telemetric communication means and/or a sensor is powered by charge stored on a capacitor.
- the means for charging said capacitor comprises a piezoelectric device, such as a polyvinylidene fluoride (PVDF) piezoelectric device.
- PVDF polyvinylidene fluoride
- the discharging of the capacitor to power the telemetric communication means and/or a sensor may be controlled by control means.
- the control means causes the capacitor to be discharged at desired junctures, which may be at pre-determined times, or when the control means receives a control signal delivered from a device external to the body, such as an appropriate radio frequency signal. It is possible for the means for charging said capacitor using energy associated with a physiological event to also act as a sensor. Piezoelectric sensors are particularly useful in this regard.
- the telemetric communication means is a transponder.
- the telemetric communication means is an RF tag transponder.
- the telemetric communication means may be powered by an RF field.
- the telemetric communication means may transmit data using an RF field.
- the telemetric communication means may transmit data by other means and/or be powered by other means, such as microwave or other electromagnetic radiation, acoustic signals or other electromagnetic fields.
- the telemetric communication means may utilise technology known in the field of mobile telephones (also known as cell telephones).
- the telemetric communication means may transmit data using Bluetooth®, WLAN, GSM, GPRS or UMTS technology.
- the telemetric communications means comprises an integrated circuit.
- the telemetric communication may comprise a chip, preferably a microchip.
- At least one sensor may be a pressure sensor for sensing blood pressure.
- highly relevant clinical pressure data such as systolic and diastolic pressures, and pressure profiles as a function of time, can be obtained.
- leakage can be detected by detecting changes in pressure. Leakage from vascular implants such as vascular grafts can be advantageously detected in this manner.
- the medical device comprises at least two spaced apart pressure sensors for sensing blood pressure at different locations, such as different locations in the heart of the patient.
- the telemetric communication means may telemetrically transmit data related to the difference in the blood pressures sensed by the at least two pressure sensors.
- At least one sensor may be an acoustic sensor for sensing acoustic signals.
- acoustic sensor for sensing acoustic signals.
- highly relevant clinical data relating to heart beat can be obtained.
- the performance of the valve(s) repair may be assessed, taking into consideration any abnormal rhythm and thus pressure profiles that might affect the interpretation of the telemetrically produced acoustic signal of the valve(s) performance.
- information relating to blood flow e.g., whether blood flow is normal or abnormal, can be obtained.
- the one or more sensors comprise at least one pressure sensor and at least one acoustic sensor for sensing blood pressure and acoustic signals. Blood pressure, pressure profiles and pressure differences may be sensed. A single sensor may sense blood pressure and acoustic signals.
- One or more sensors may sense other physiologically relevant parameters, such as temperature, pH, CO 2 and O 2 .
- At least one sensor may be a passive sensor, i.e., a sensor that does not require a power source in order to operate as a sensor.
- At least one sensor may be a piezoelectric sensor.
- the piezoelectric sensor may comprise a polymeric active sensing area and the polymeric active sensing area may comprise polyvinylidene fluoride (PVDF) or a related PVDF material.
- PVDF is a preferred material since it is possible to provide PVDF sensors that can monitor both pressure and acoustic signals.
- Related PVDF materials include copolymers with PVDF, such as a PVDF-trifluorethylene (TrFe) copolymer.
- An alternative piezoelectric sensor is a quartz crystal sensor.
- sensors might be employed such as conductimetric sensors.
- Examples of other sensor types include electret sensors, sensors comprising carbon particles suspended in a polymer matrix, and electrochemical sensors, especially passive electrochemical sensors.
- the sensors and telemetric communication means may be disposed on a medical device so that, when implanted as a heart valve, these elements are situated either in an intravascular configuration or in an extravascular configuration.
- the sensors can be disposed so as to be in direct contract with blood once implanted. This provides higher signal values. However, it is generally preferred that the sensors are disposed so as to be out of direct contact with the blood, such as on the external surface of a valve implant or within any material utilised for valve repair of an indigenous valve. Such a sensor or group of sensors may be outside the main blood flow stream.
- At least a portion of the medical device may be coated with a non-thrombogenic or anti-thrombogenic, bio-compatible substance.
- the one or more sensors may be coated in this manner.
- the one or more sensors and telemetric communication means may be sealed within a bio-compatible protective structure.
- the protective structure may be coated with a non-thrombogenic or anti-thrombogenic bio-compatible substance.
- the medical device may be a tissue valve device having a valve wall formed from tissue.
- the medical device may be stented or stentless.
- the medical device may further comprise a stent support for the valve wall, in which at least one sensor and the telemetric communication means are disposed between the stent support and the valve wall.
- a tissue valve medical device may further comprise a protective cover disposed around the periphery of the device, and the at least one sensor and the telemetric communication means may be disposed between the valve wall and the protective cover.
- the protective cover may comprise a polymeric layer, such as Dacron® or a pericardial layer, typically one that has been crosslinked.
- the medical device may be a mechanical heart valve.
- a medical device of the invention may comprise a plurality of sensing units, each sensing unit comprising one or more sensors for sensing a physiologically or clinically relevant parameter and associated telemetric communication means for telemetrically transmitting data related to a parameter sensed by the one or more sensors to a remote device.
- the medical device is a vascular graft or a stent.
- a plurality of sensing units can be disposed along the length of the vascular graft or stent.
- the sensing units might be disposed linearly or in a non-linear arrangement, such as a spiral arrangement. In this way, dynamics along the length of the stent or graft can be monitored. Additionally, blood pressure differential between selected portions of the stent or graft can be monitored, and blood flow velocities obtained.
- a plurality of separate implants are placed along a desired target such as a vessel.
- a system for monitoring a patient comprising: a medical device according to the first aspect of the invention; and a remote device for receiving data telemetrically transmitted by the telemetric communication means.
- the remote device may be adapted to provide power remotely to the telemetric communication means.
- the remote device may be adapted to produce an RF field for this purpose.
- the remote device may comprise memory for storing data transmitted by the telemetric communication means.
- the remote device may comprise data analysis means for performing a physiologically or clinically relevant analysis of data transmitted by the telemetric communication means.
- data analysis is provided by the instance in which two or more sensors sense blood pressure at different locations in the heart of the patient.
- the remote device (or another component in the system) may calculate a quantity related to the difference in the blood pressures sensed by the two or more sensors. This quantity may be integrated with acoustic or other relevant clinical data, thus aiding enhanced clinical evaluation of the performance of the valve or valve replacement, particularly over time between patient examinations.
- the remote device may comprise data transmission means.
- the data transmission means may comprise an interface suitable for sending data to the outside world, preferably to a computer.
- Data may be sent via a network, suitable but non-limiting examples of which are a wide area network (WAN), a local area network (LAN), an intranet, a worldwide computer network, and the Internet.
- WAN wide area network
- LAN local area network
- intranet a worldwide computer network
- worldwide computer network a worldwide computer network
- the system may further comprise a data storage device which is separate to the remote device, in which the remote device comprises means to write data on the data storage device.
- the data storage device may be a card having a magnetic data storage area, a digital versatile disc (DVD), a compact disc (CD) or another disc data storage medium.
- DVD digital versatile disc
- CD compact disc
- a record of in vivo data may be built up in a highly convenient manner.
- the assembled data record on the data storage device might be transported to a skilled physician for analysis and interpretation of the data in order to assess the patient, and/or might be used to assess the performance of the medical device itself. In either instance, the analysis, interpretation or assessment might be performed at a location which is remote from the location at which data were transmitted to the remote device.
- a relay device receives data transmitted by the telemetric communication means and sends the data on to the remote device or another relay device.
- a relay device may be implanted at a suitable position in the body. Relay devices are of particular importance if the telemetric communication means possesses only a short range.
- a medical device as an implant in a body for sensing a physiologically or clinically relevant parameter.
- Uses include in the heart, other organs, vessels, lungs, orthopaedic uses, neurosurgical uses, the urinary system, the digestive system, intensive care monitoring and use with transplanted organs such as the kidneys, liver, or heart, for example, to assess flow and pressure differentials on in-flow and out-flow vessels as a guide to rejection or response to therapy.
- a preferred but non-limiting embodiment comprises the use of medical devices in the treatment and/or monitoring of an Abdominal Aortic Aneurysm (AAA), in particular in the instance in which the medical device is an AAA graft.
- AAA Abdominal Aortic Aneurysm
- Vessels might be arteries, such as the pulmonary artery and the aorta, and veins.
- Use in intensive care monitoring includes the placement of medical devices of the invention on vessels, such as the pulmonary artery and the aorta in one or more positions, for example, to measure cardiac output and filling pressures at or after open operations such as heart and lung operations.
- the device may also be used in non-surgical cases where patients have life threatening conditions such as trauma, heart failure or septicaemia.
- Orthopaedic use includes use on ligaments and joints, for example onto joint capsules or into joint replacement such as hips and knees where stress/strain is an important additional measurement.
- Neurosurgical use includes measurement of intracranial pressure and intraspinal pressures.
- Devices of the invention might be placed on the membrane of the brain (dura).
- Use relating to the lung includes the detection of airway obstruction, particularly in asthma cases, and also measuring the response of asthma cases and other lung conditions to medications.
- Lung conditions such as emphysema, chronic bronchitis, and other forms of restrictive airway disease might be monitored.
- Urinary system use includes measurement of bladder pressure, ureteric flow or back flow, and urinary flow. Further uses relate to valve repair and carotic patches following endarterectomy. In the latter instance carotic flows can be measured, and the device can be sewn in place. ECG measurements might be made.
- Preferred uses of the invention include uses relating to stents and vascular grafts.
- Vascular grafts may be with or without stents.
- the medical devices of the invention may themselves comprise the stent or vascular graft itself, or, alternatively, the medical device may be disposed on, in, or in the vicinity of the stent or vascular graft.
- the medical device may be used to monitor the performance of the stent or vascular graft, for example, by detecting whether leakage or stenosis is occurring, or to assess whether the stent or vascular graft has moved.
- stents include pulmonary, vascular, coronary, thoracic and abdominal stents.
- Non-limiting examples of grafts include AAA, infrainguinal, femoral popliteal, femoral distal, vein and vascular access grafts.
- vascular access grafts include grafts for patients requiring dialysis and paediatric cardiac conduits. Digestive system measurements may be made, for example, pH and pressure, particularly in the oesophagus, stomach and bowel.
- a medical device according to the first aspect of the invention as a heart valve and in sensing a physiologically or clinically relevant parameter.
- a medical device according to the first aspect of the invention to assist in the functioning of one of a patient's heart valves and in sensing a physiologically or clinically relevant parameter.
- a medical device in, on or in the immediate environs of the heart valve of a patient to sense a physiologically or clinical relevant parameter and thereby monitor the functioning of said heart valve.
- FIG. 1 is a side view of a stented heart valve in accordance with the invention
- FIG. 2 is a plan view of the heart valve of FIG. 1 ;
- FIG. 3 is a cross sectional view of the heart valve of FIG. 1 , taken along the line the line 3 - 3 of FIG. 2 ;
- FIG. 4 is an enlarged view of a portion of the heart valve as shown in FIG. 3 ;
- FIG. 5 is a side view of a freesewn heart valve in accordance with the invention.
- FIG. 6 is a plan view of the heart valve of FIG. 5 ;
- FIG. 7 is a cross sectional view of the heart valve of FIG. 5 , taken along the line 7 - 7 of FIG. 6 ;
- FIG. 8 is an enlarged view of a portion of the heart valve as shown in FIG. 7 ;
- FIG. 9 shows an arrangement of two sensors and telemetric communication means
- FIG. 10 shows a system in accordance with the invention
- FIG. 11 is a cross-sectional view of an AAA graft of the invention installed within a heart.
- FIG. 12 shows the response of a sensor downstream of porcine tissue heart valve.
- FIGS. 1-4 show a first embodiment of a heart valve 10 according to the invention.
- the heart valve 10 is a stented tissue valve comprising a stent 12 which supports a tissue valve wall 14 obtained from a suitable source. Typically, porcine tissue valves are utilised.
- the tissue valve 10 further comprises a valve 16 , the valve 16 being made up of three tissue leaflets 16 a, 16 b, 16 c.
- a protective cover 18 is provided around the periphery of the valve wall 14 /stent 12 .
- the cover may be produced from any suitable material: typically, a polymeric sheet material such as Dacron® is used, although the invention is not limited in this regard. As shown to best effect in FIG.
- the tissue heart valve 10 further comprises a first sensor 20 , a second sensor 22 , and telemetric communication means 24 , all of which are disposed in the cavity provided between the valve wall 14 and stent 12 .
- This location is extremely convenient, since blood flowing through the tissue heart valve 10 is not in direct contact with the sensors 20 , 22 or telemetric communication means 24 , but the sensors are sufficiently close to the blood flow to be able to detect certain desired parameters associated with the blood flow with good sensitivity. As will be explained in more detail below, it is desirable that the sensors 20 , 22 are disposed on either side of the valve 16 .
- FIGS. 4-8 depict a second embodiment of the present invention which is a free sewn (or stentless) tissue heart valve 30 .
- the tissue heart valve 30 comprises a tissue valve wall 32 and a tissue valve 34 , the tissue valve 34 itself comprising a plurality of leaflets 34 a, 34 b, 34 c. Again, it is typical that porcine tissue is used to fabricate the tissue heart valve 30 , although the invention is not limited in this regard.
- the tissue valve 30 further comprises a protective layer 36 , which typically is a crosslinked pericardial cover also obtained from sources of porcine tissue.
- the tissue heart valve 30 further comprises a first sensor 38 , a second sensor 40 and telemetric communication means 42 which are disposed between the valve wall 32 and the pericardial cover 36 .
- first and second sensors 38 , 40 are disposed on either side of the valve 34 . Additionally, it is highly advantageous that the sensors 38 , 40 and telemetric communication means 42 are situated in a location which is not in direct contact with blood flowing through the heart valve, but which is close enough to enable the desired parameters to be sensed with good sensitivity.
- FIG. 11 shows a third embodiment of the invention in which the device is an AAA graft 70 having one or more sensors and telemetric communication means coupled thereto.
- the device is an AAA graft 70 having one or more sensors and telemetric communication means coupled thereto.
- an endoscopic procedure is used to position the AAA graft 70 in an aneurysm sac 72 .
- the main aorta 74 is also shown in FIG. 11 .
- the AAA graft 70 is a bifurcated structure having a main conduit 70 a and first and second branches 70 b, 70 c.
- the AAA graft 70 comprises an extendable structure 70 d disposed at the top end of the graft and an extendable structure 70 e disposed on the main conduit 70 a and first and second branches 70 b, 70 c as is well known in the art. These extendable structures are used to anchor the graft in place.
- the AAA graft 70 further comprises one or more extension means 76 on which sensors 78 and telemetric communication means 80 are disposed.
- the extension means 76 of the third embodiment operate in much the same manner as the conventional attachment structures used to position vascular grafts and stents, in that the extension means 76 lie substantially flush with the graft 70 before use, but once in position are caused to extend from the external surface of the graft 70 by the action of expanding a catheter balloon, or blood flow. It is also possible to dispose the sensors and telemetric communication means on an otherwise conventional extendable structure system, or to dispose them on an external surface of the graft 70 . In another variant, the sensors and telemetric communication means may be disposed on an interior surface of the graft.
- Positioning of the sensors and telemetric communication means on the exterior of the AAA graft 70 is preferred, however, since it addresses a major problem associated with AAA grafts, namely the problem of measuring pressure inside the aneurysm sac 72 , but outside the graft 70 .
- suitable sensors such as pressure sensors
- Pressure sensors are particularly useful in this regard, but the invention is not limited to this way.
- One problem that can be detected is that of leakage into or out of the aneurysm sac 72 and out of the graft 70 . Areas of possible leaks are shown by way of arrows in FIG. 11 .
- One or more sensors may be employed in the present invention in order to sense one or more physiologically or clinically relevant parameters. Examples of such parameters include pressure, acoustic signals, temperature and pH. Chemical sensors and biosensors might be used in order to analyse blood flowing through a heart valve. Pressure and acoustic signal measurements are particularly important. Measurement of pressure can provide systolic and diastolic pressure information. Furthermore, it is possible to obtain useful information by examining the differences in pressures measured by two or more pressure sensors. Particularly useful information is obtained when sensors are disposed either side of the valve, such as described above in relation to the first and second embodiments of the invention. In this way, blood flow can be assessed, and leakage across or from the valve can be detected.
- Measurement of pressure difference enables the instantaneous blood flow velocity to be calculated using Bernoulli's equation. Bernoulli's equation incorporates a velocity squared term.
- Doppler ultrasound methods are employed to measure velocity by projecting an ultrasound beam as closely as possible to the axis of the aorta. Small angular deviations from the axis result in potentially large inaccuracies in the velocity data, any errors in which are magnified by the dependence of Bernoulli's equation on velocity squared.
- velocity can be inferred directly from a differential pressure measurement.
- the present invention offers the possibility of improved measurement of velocity and hence blood flow or cardiac output.
- PVDF transducer it is advantageous to utilise piezoelectric sensors in devices of the present invention, although the invention is not limited in this regard.
- at least one PVDF based transducer is utilised.
- An advantage associated with PVDF transducers is that they can be operated as both a pressure transducer and as a microphone, monitoring acoustic signals. In the pressure transducer mode, the PVDF transducer is reacting to blood pressure during the heart cycle. In the microphone mode, the PVDF transducer is listening to the sounds emitted by the blood as it moves through the heart valve. This requires that the PVDF transducer has a band width out to 1 or 2 kHz.
- a piezoelectric material such as PVDF will respond to electric field changes so as to permit ECG measurements to be made.
- PVDF is inherently a very high electrical impedance material, but in the context of acoustic signals, it is not necessary to use very thin materials.
- a PVDF thickness of between 60 and 150 ⁇ m, preferably between 60 and 110 ⁇ m, is used. It is advantageous that it is possible to use relatively large area transducers. Other piezoelectric materials might be used in place of PVDF. In particular, there are numerous polymer based composite materials which could be used. Lead zirconate titantate (PVT) and quartz crystals are examples of other suitable piezoelectric materials which are not polymeric in nature. Miniature quartz crystals can be obtained which have thicknesses around 150 ⁇ m and areas of 1 to 2 mm 2 . Such sensors can be set to resonate in a shear mode, and the resonant frequency is extremely sensitive to outside interferences such as pressure.
- pressure changes can be monitored by monitoring changes in self-resonant frequency.
- the oscillation of the quartz crystal can be sustained with a form of feedback provided by a small electronic circuit.
- This operation can be powered using externally applied energy such as RF signals, or by a charged capacitor which can be charged according to methodologies explained elsewhere in this description.
- sensors suitable for use in conjunction with the present invention include electrets and sensors comprising particles of carbon suspended in a polymer matrix.
- An electric microphone might be used to pick up, for example, heart sounds and blood flow sounds.
- a DC bias voltage may be required.
- Sensors comprising fine particles of carbon suspended in a soft polymer matrix can be used to transduce heart and valve sounds, blood flow sounds, and also pressure signals. It is likely that the thickness of such sensors would be greater then 100 microns, although the invention is not limited in this regard.
- Transduction can be achieved by making resistance measurements.
- Energy for interrogation methodologies such as the provision of bias voltages and resistance measurements can be provided using charge stored on a capacitor, preferably a micro-miniature capacitor. The capacitor can be charged according to methodologies explained elsewhere in this description.
- FIG. 12 shows signal obtained from a sensor disposed on the downstream side of a porcine tissue heart valve. Data processed using a 50-100 Hz band block filter are shown. A feature can be observed at 20 ms which corresponds to the opening of the valve. A further feature at ca. 85 ms may correspond to the closing of the valve.
- FIG. 9 shows a sensing arrangement comprising two sensors 50 , 52 in connection with telemetric communication means 54 through wiring 56 , such as gold wires.
- the function of the telemetric communication means 54 is to telemetrically transmit data related to a parameter sensed by one or more of the sensors 50 , 52 to a remote device.
- the medical devices provided by the present invention are intended to be able to transmit data obtained in vivo within a patient who has had the heart valve implanted therein, the data being transmitted out of the body of the patient.
- the heart valve might be implanted in any of the precise locations in the heart that known heart valves are implanted, using known surgical techniques.
- the data will be directly transmitted from the telemetric communication means to a remote device disposed outside of the body of the patient.
- a remote device disposed outside of the body of the patient.
- This device might transmit data (possibly after performing datalogging or data analysis functions) to a further device disposed outside of the body of the patient.
- the telemetric communication means 54 is a so-called RF tag device (such devices are also known as radio frequency identification (RFID) chips—see, for example, UK periodical “Computing”, 16 Jan. 2003 edition). Such devices are well known for position monitoring purposes.
- RFID radio frequency identification
- RF tag devices are passive devices until interrogated by a suitable, and typically relatively powerful, RF signal.
- the signal is energetic enough to power up the RF tag device which, in the context of position measurement, typically responds with some form of electronic bar code signal, typically using a response frequency around 450 MHZ.
- the function of the RF tag is altered somewhat from these prior art applications.
- the RF tag accepts data from the sensors, and transmits data relating to measurements made by the sensors to the interrogating remote device.
- One way in which this can be achieved is to use the signal from the sensors to modulate the response from the RF tag in a suitable manner.
- a preferred way in which data is transmitted by the RF tag is by modification of the ID code of the RF tag in response to the data accepted from the sensors.
- Other methods for transmitting data such as modulating the data transmission rate of the RF tag, might be contemplated. Suitable powering and data collection regimes would suggest themselves to the skilled person. For example, an RF tag might be powered up at a frequency of 2 Hz and data collected at a frequency of 10 Hz. Further information concerning the operation of RF tags can be found in International Patent Publication WO 02/073523 and U.S. Pat. No. 6,622,567, the contents of both of which are herein incorporated by reference.
- the remote device accepts the data transmitted telemetrically by the RF tag device, and can perform desired functions such as datalogging, data analysis and data presentation. Additionally, the remote device transmits a RF signal to the telemetric communication means in order to power said telemetric communication means. Alternatively, it may be possible to build some or all of the datalogging and data analysis functions into the functionality of the telemetric communication means.
- the data obtained using the present invention are communicated to a site which is different to the site at which the in vivo measurements were made.
- a site which is different to the site at which the in vivo measurements were made.
- the in viva measurements are accessible locations such as a general practitioner's surgery or the patient's abode.
- a physician or other skilled person who is intended to analyse the data that the data may be conveyed in some way to a location which is convenient for that skilled person.
- the present invention is highly convenient in this regard, since the remote device can be configured to transmit data over a network such as a WAN, LAN, intranet, worldwide computer network, or the internet.
- the remote device might write the data to a suitable data storage device such as a DVD, a CD or another form of disc storage medium.
- the remote device might be configured to write data to a card having a suitable data storage area such as a magnetic data storage area.
- the patient can be provided with a “swipe card” on which relevant data can be written.
- the swipe card can then be conveyed to an interested party for data analysis.
- FIG. 10 depicts one embodiment of a system 60 of the invention comprising a remote device 62 and a heart valve 64 .
- the heart valve 64 has telemetric communication means 66 for telemetrically transmitting data to the remote device 62 .
- the heart valve 64 is implanted in the heart of a patient (not shown).
- the remote device 62 has a slot 66 through which a swipe card 68 can be translated, thereby permitting data recorded by the heart valve 64 to be stored on the swipe card 68 .
- the first and second embodiments discussed above utilise sensors and telemetric communication means which are, strictly speaking, anchored intravascularly, since these components are disposed inside of the vascular “tree”. It is also possible to dispose these components in an extravascular configuration, or to position them in a strict intravascular sense, i.e., disposed in the blood flow.
- the sensors and telemetric communication means may be protected by a suitable shell, layer or membrane, or even encapsulated by same.
- a passive telemetric communication means might be powered by means other than the supply of RF energy.
- the heart valve might be provided with coils which can be powered up using externally supplied electromagnetic fields other than RF fields.
- “active” telemetric communication means rather than a passive one, which is powered internally, allowing continuous or near continuous operation.
- the sensors may be powered in the same manner.
- data from the sensors might be accumulated continuously, rather than on demand when interrogated by the remote device.
- datalogging and data analysis functions There are numerous possibilities regarding datalogging and data analysis functions. For example, it may be desirable to only store, process, or notify the existence of data which relate to adverse events.
- mechanical heart valves which incorporate in vivo sensing capabilities of the type generally described above.
- it is possible to “retrofit” to existing heart valves in order to provide modified existing heart valves so as to provide the in vivo sensing capabilities of the present invention.
- Heart valve repair devices are quite commonly used to repair mitral heart valves, although the invention is not limited in this regard.
- a support structure such as a hoop is used, the support structure being sewn into the top of the valve.
- the hoop may comprise a plastic and may be provided with a cloth cover. It would be possible to dispose the sensor(s) and telemetric communication means within or on such a support structure.
Abstract
There is disclosed a medical device for implantation in a body comprising: one or more sensors for sensing a physiologically or clinically relevant parameter; and telemetric communications means for telemetrically transmitting data related to a parameter sensed by the one or more sensors to a remote device.
Description
- This application is a continuation-in-part of U.S. application Ser. No. 10/718,057 filed on Nov. 20, 2003 which claims the benefit of United Kingdom Patent Application No. 0325679.9, filed on Nov. 4, 2003, and this application claims the benefit of United Kingdom Patent Application No. 0417628.5 filed Aug. 9, 2004 which hereby is incorporated by reference in its entirety.
- 1. Field of the Invention
- This invention relates to medical devices and systems that incorporate said medical devices, with particular, but by no means exclusive, reference to heart valve devices, vascular grafts, stents and other implantable devices.
- 2. Description of the Art
- Heart valves are well known medical devices which are intended to replicate the function of the valves of the human heart, i.e., to regulate the flow of blood into or out of the chambers of the heart. Known heart valves can be categorised into two main types, namely mechanical heart valves and tissue heart valves. With mechanical valves, the entire valve is constructed from non-biological material, which may be a synthetic or man-made material. They may comprise a tilting disc or occluder or incorporate a bileaflet design. Many mechanical valves, both occluders or bileaflet, are made, for example, from pyrolytic carbon. The disc or leaflets may be housed in a ring of titanium, for example, and coated with pyrolytic carbon. Mechanical valves usually have a sewing cuff to aid the surgeon's implantation of these devices. They are usually made of a surgical cloth, either Dacron® or Teflon. In contrast, tissue valves are fabricated, at least in part, using tissue obtained from a suitable living source. This tissue is treated, particularly chemically, to prevent degeneration, to reduce antigenicity and to extend shelf life of the valves as well as to strengthen them. Typically, the tissue element uses porcine (pig) aortic valves with part of the aortic artery wall. Thus, porcine valve leaflets are a part of the integral functioning valve. Some tissue valves are fabricated from pericardial pieces, fashioned by shaping the pericardial tissue into artificial leaflets. (The pericardium is part of the membrane surrounding the heart.) The majority of tissue valves are made from porcine aortic valves. They may be used after trimming etc, by themselves (freesewn valves or roots) or may be sutured into a synthetic frame (stented tissue valves). Plastic mono or homopolymers are examples of such frame materials. These stented or framed bioprosthetic tissue valves frequently have a sewing cuff added to ease implantation, similar to mechanical valves. These cuffs may be made of surgical cloth, e.g., Dacron® or Teflon® and may incorporate a cloth filler, e.g. Dacron®. Some sewing cuffs on these valves are made from pericardium. The majority of stented valves have the frame additionally covered by surgical cloth, into which the porcine material is attached by sutures. Some freesewn porcine valves are covered with a layer of pericardium. It will now be apparent that, broadly speaking, tissue valves can be categorised into two sub-sections. More specifically, stented tissue valves utilise a stent support for the tissue valve wall whereas, in contrast, stentless tissue valves do not utilise supports of this type for the tissue valve wall, and require extra layers of sutures in order to provide a usable product. It is generally recognised that stentless (also known as free sewn or free-stent) tissue valves provide better haemodynamic performance, but suffer from the disadvantages of being rather difficult to implant and difficult to size properly.
- The use of heart valves is widespread, with more than 180,000 heart valve operations being performed every year in the western world alone. It is likely that the annual number of heart operations will increase still further in the future. However, there are a number of problems associated with known heart valve devices. Firstly, there is a need to monitor patients who have had heart valves fitted. At present, this postoperative monitoring process may be inconvenient, resource intensive, and expensive. In particular, monitoring is most efficaciously performed through echocardiography, which requires the provision of expensive ultrasound equipment and suitably skilled staff to perform studies and interpret results. Necessarily, such resources are only maintained at relatively large institutions such as hospitals, and thus require patients to travel (possibly over long distances) to attend a check up, which may be inconvenient. A related problem is that access to echocardiography monitoring is limited. In fact, it is the case that implanted heart valve dysfunction associated with abnormal valve action caused by complications such as thrombosis formation or tissue ingrowth tends to develop over a period of several weeks. This period can occur between the initial monitoring by echocardiography and further physical examinations. Additionally, it would be highly desirable to obtain feedback on the clinical performance of a heart valve over a period of time. However, there is currently no readily available method for performing an in vivo assessment of this type which is not invasive or minimally invasive, or indeed avoids patients and clinicians waiting for appointments for full assessment to be performed. It is also not easy and somewhat subjective to compare one study with another or to evaluate the gradual changes over a period of time. Eitz et al (T Eitz, D Fritzsche, O Grimmig, I Frerichs, A Frerichs, G Hellige, K Minami and R Korfer, J. Heart Valve Dis. 12 (2003) 414) discloses an approach to the monitoring of heart valves in which patients are trained to use briefcase sized acoustic detection devices to investigate heart functions and to transmit the data thus acquired. It is a disadvantage that the approach is entirely reliant on training the patients to perform an analytical technique and on the ability of the patients to properly perform the technique. US 2002/0072656 A1 and U.S. Pat. No. 6,409,675 (the contents of which are herein incorporated by reference) disclose apparatus which are implanted into the vascular system of an individual and which are capable of providing information relating to clinically important parameters. The apparatus disclosed does not relate to heart valves and in particular to either valve replacement, either mechanical or tissue, or indeed to assessing the results of surgical invasive or minimally invasive procedures to repair or treat indigenous valve disorders or problems.
- Further prior art relating to the collection of in vivo data in a body comprises U.S. Pat. Nos. 6,667,725, 6,486,588, 6,729,336, 6,645,143, 6,658,300, 5,967,986, 6,743,180 and 6,592,518; US Patent Application 2003/0136417; and International Patent Publications WO 03/061467, WO 03/061504 and WO 04/014456, the contents of all of which are herein incorporated by reference.
- The present invention addresses the above named problems, and, in particular, provides a straightforward, efficacious and economic means of obtaining clinically and physiologically useful in vivo data relevant to a patient. Such data include the condition of a heart valve implant or repair or other indigenous valve treatment, and the performance of the heart valve. The in vivo data can be easily obtained on a regular basis over an extended time frame. Further, data can be obtained without requiring the attention of skilled operatives so as to provide the attendant clinical staff with an assessment of any changes, either acute or chronic, occurring since the time of implant or treatment, such as changes in valve, stent or graft performance.
- For the avoidance of doubt, the terms “patient” and “body” as used herein includes both humans and animals within its scope.
- According to a broad aspect of the invention there is provided a medical device for implantation in a body comprising:
- one or more sensors for sensing a physiologically or clinically relevant parameter; and
- telemetric communication means for telemetrically transmitting data related to a parameter sensed by the one or more sensors to a remote device.
- According to a preferred aspect of the invention there is provided a medical device adapted to be implanted in the heart of a patient and operable therein i) as a heart valve; or ii) to assist in the functioning of one of the patient's heart valves; or iii) to monitor the functioning of one of the patient's heart valves; the device comprising: one or more sensors for sensing a physiologically or clinically relevant parameter; and telemetric communication means for telemetrically transmitting data related to a parameter sensed by the one or more sensors to a remote device.
- In the case of option i), above, the medical device is a heart valve which may further comprise a valve for regulating the flow of blood through the device. Typically, the valve comprises a number of leaflets, although this is not a limiting feature of the invention.
- In the case of option ii), above, the medical device may comprise a heart valve repair device. The heart valve repair device may comprise a heart valve support structure, such as an annular support structure. Such annular structures may be sewn onto a patient's dysfunctional heart valve.
- In the case of option iii), above, the medical device may comprise a structure suitable for placement in or on a patient's heart valve. The patient's heart valve may be a treated indigenous valve or a valve which, although untreated, might require monitoring to determine when or if future treatment or replacement is required.
- In other preferred embodiments, the medical device further comprises a support structure to which the one or more sensors and telemetric communication means are coupled. The support structure may be a graft, such as a vascular graft. A non-limiting example of a vascular graft is an Abdominal Aortic Aneurysm (AAA) graft. Alternatively, the support structure may comprise a stent. Examples of stents include coronary stents and vascular stents. The stents may be employed in blood vessels, such as the peripheral vascular tree, or the aorta, for example. It should be noted that vascular grafts may be employed with or without stents. Drug Elutant Stents (DES) which release an anti-thrombogenic drug might be used. The sensors and telemetric communication means may be located on the inside or the outside of a stent or a graft. Alternatively, the sensors may be located on the inside and the telemetric communication means on the outside or vice versa.
- In embodiments in which a support structure is a vascular graft, the device may further comprise extension means disposed on an external surface of the vascular graft and operable so as to extend therefrom; in which at least one of the telemetric communication means and the one or more sensors is disposed on the extension means. Conveniently, the extension means can be stored in an unextended form, the unextended form being used for introduction of the graft into a body. Once implanted in the body, the extension means can be extended from the vascular graft. In embodiments in which the vascular graft is inserted using a balloon catheter, it is preferred that the extension of the extension means is achieved by way of expansion of the balloon. The extension means can be, for example, a wire, wire structure, fibre or fibre structure which may be raised on the surface of the vascular graft once the catheter balloon is inflated. In other embodiments, the one or more sensors and telemetric communications means are disposed on an interior or an exterior surface of a vascular graft or stent.
- In other embodiments, the device is an implant. The implant may be attached to a desired body part by suitable means, such as by suture or adhesive. In preferred embodiments, the medical device is in a form suitable for injection into a body. The term “a form suitable for injection into a body” means that the device is at least capable of being introduced into a body in a clinically acceptable manner, for example, via an endoscope. It may be possible to provide a medical device suitable for injection using smaller injection means, such as a hypodermic needle.
- In further embodiments of the invention, the medical device is an artificial heart or a left ventricular support device (LVad). Such devices contain artificial heart valves. It is possible for the sensors and telemetric communication means to be disposed on the artificial heart valves, or, alternatively, the sensors and telemetric communication means may be disposed elsewhere within or on the device.
- In preferred embodiments, the telemetric communication means is a passive device. For example, the device may be powered by energy transmitted by a remote device, in which instance the telemetric communication means may be a transponder, such as an RF tag device, or Radio Frequency Identification (RFID) device.
- The medical device may further comprise a capacitor and means for receiving an externally applied source of energy and charging said capacitor using the externally applied source of energy, in which the telemetric communication means and/or a sensor is powered by charge stored in the capacitor. For example, an external radio frequency source can be used to charge a capacitor which would gradually discharge and power up the telemetric communication means and/or a sensor. The commencement of the powering of the telemetric communication means and/or a sensor by the capacitor can be controlled by control means. The control means causes the capacitor to be discharged at desired junctures, which may be at pre-determined times, or when the control means receives a control signal delivered from a device external to the body, such as an appropriate radio frequency signal.
- Alternatively, the telemetric communication means may be powered by an energy source disposed on or in physical connection with the medical device, such as a battery.
- Alternatively still, it may be possible to utilise energy produced by the patient, in particular energy associated with the beating of a patient's heart or other bodily functions which alter pressure to power the telemetric communication means. In such embodiments, the medical device may further comprise a capacitor and means for charging said capacitor using energy associated with a physiological event, in which the telemetric communication means and/or a sensor is powered by charge stored on a capacitor. Preferably, the means for charging said capacitor comprises a piezoelectric device, such as a polyvinylidene fluoride (PVDF) piezoelectric device. The piezoelectric device can produce the necessary electrical charge by transduction of the pulsating pressure changes inherent in blood pumped by the heart. The discharging of the capacitor to power the telemetric communication means and/or a sensor may be controlled by control means. The control means causes the capacitor to be discharged at desired junctures, which may be at pre-determined times, or when the control means receives a control signal delivered from a device external to the body, such as an appropriate radio frequency signal. It is possible for the means for charging said capacitor using energy associated with a physiological event to also act as a sensor. Piezoelectric sensors are particularly useful in this regard.
- In preferred embodiments of the invention, the telemetric communication means is a transponder. In particularly preferred embodiments, the telemetric communication means is an RF tag transponder.
- The telemetric communication means may be powered by an RF field.
- The telemetric communication means may transmit data using an RF field.
- The telemetric communication means may transmit data by other means and/or be powered by other means, such as microwave or other electromagnetic radiation, acoustic signals or other electromagnetic fields.
- In further embodiments, the telemetric communication means, the means by which the telemetric communication means transmits data and the means by which the telemetric communication means is powered may utilise technology known in the field of mobile telephones (also known as cell telephones). In such embodiments, the telemetric communication means may transmit data using Bluetooth®, WLAN, GSM, GPRS or UMTS technology.
- The telemetric communications means comprises an integrated circuit. The telemetric communication may comprise a chip, preferably a microchip.
- At least one sensor may be a pressure sensor for sensing blood pressure. In this way, highly relevant clinical pressure data, such as systolic and diastolic pressures, and pressure profiles as a function of time, can be obtained. Additionally, leakage can be detected by detecting changes in pressure. Leakage from vascular implants such as vascular grafts can be advantageously detected in this manner. Advantageously, the medical device comprises at least two spaced apart pressure sensors for sensing blood pressure at different locations, such as different locations in the heart of the patient. In this instance the telemetric communication means may telemetrically transmit data related to the difference in the blood pressures sensed by the at least two pressure sensors. In this way, information on blood flow and blood leakage can be obtained, particularly pressure differences across a valve or valve replacement, giving valuable data concerning valve narrowing/stenosis/incompetence. Pressure data including instantaneous pressure data can be obtained. Additionally, instantaneous blood velocity can be calculated using Bernoulli's equation (Lecture Notes on Cardiology, A Leatham, 3rd edition, Blackwell Scientific 1991, page 47 (ISBN 0-632-01944-1)). It is anticipated that blood velocities measured using devices of the present invention will be more accurate than those calculated using the current medical standard technique of Doppler ultrasound measurement.
- At least one sensor may be an acoustic sensor for sensing acoustic signals. In this way, highly relevant clinical data relating to heart beat can be obtained. In particular the performance of the valve(s) repair may be assessed, taking into consideration any abnormal rhythm and thus pressure profiles that might affect the interpretation of the telemetrically produced acoustic signal of the valve(s) performance. Additionally, information relating to blood flow, e.g., whether blood flow is normal or abnormal, can be obtained.
- Advantageously, the one or more sensors comprise at least one pressure sensor and at least one acoustic sensor for sensing blood pressure and acoustic signals. Blood pressure, pressure profiles and pressure differences may be sensed. A single sensor may sense blood pressure and acoustic signals.
- One or more sensors may sense other physiologically relevant parameters, such as temperature, pH, CO2 and O2.
- At least one sensor may be a passive sensor, i.e., a sensor that does not require a power source in order to operate as a sensor.
- At least one sensor may be a piezoelectric sensor. The piezoelectric sensor may comprise a polymeric active sensing area and the polymeric active sensing area may comprise polyvinylidene fluoride (PVDF) or a related PVDF material. PVDF is a preferred material since it is possible to provide PVDF sensors that can monitor both pressure and acoustic signals. Related PVDF materials include copolymers with PVDF, such as a PVDF-trifluorethylene (TrFe) copolymer. An alternative piezoelectric sensor is a quartz crystal sensor.
- Other types of sensors might be employed such as conductimetric sensors. Examples of other sensor types include electret sensors, sensors comprising carbon particles suspended in a polymer matrix, and electrochemical sensors, especially passive electrochemical sensors.
- The sensors and telemetric communication means may be disposed on a medical device so that, when implanted as a heart valve, these elements are situated either in an intravascular configuration or in an extravascular configuration. The sensors can be disposed so as to be in direct contract with blood once implanted. This provides higher signal values. However, it is generally preferred that the sensors are disposed so as to be out of direct contact with the blood, such as on the external surface of a valve implant or within any material utilised for valve repair of an indigenous valve. Such a sensor or group of sensors may be outside the main blood flow stream.
- At least a portion of the medical device may be coated with a non-thrombogenic or anti-thrombogenic, bio-compatible substance. In particular, the one or more sensors may be coated in this manner.
- The one or more sensors and telemetric communication means may be sealed within a bio-compatible protective structure. The protective structure may be coated with a non-thrombogenic or anti-thrombogenic bio-compatible substance.
- The medical device may be a tissue valve device having a valve wall formed from tissue. The medical device may be stented or stentless. In particular, the medical device may further comprise a stent support for the valve wall, in which at least one sensor and the telemetric communication means are disposed between the stent support and the valve wall.
- A tissue valve medical device may further comprise a protective cover disposed around the periphery of the device, and the at least one sensor and the telemetric communication means may be disposed between the valve wall and the protective cover. The protective cover may comprise a polymeric layer, such as Dacron® or a pericardial layer, typically one that has been crosslinked.
- The medical device may be a mechanical heart valve.
- A medical device of the invention may comprise a plurality of sensing units, each sensing unit comprising one or more sensors for sensing a physiologically or clinically relevant parameter and associated telemetric communication means for telemetrically transmitting data related to a parameter sensed by the one or more sensors to a remote device. In preferred embodiments, the medical device is a vascular graft or a stent. In such embodiments, a plurality of sensing units can be disposed along the length of the vascular graft or stent. The sensing units might be disposed linearly or in a non-linear arrangement, such as a spiral arrangement. In this way, dynamics along the length of the stent or graft can be monitored. Additionally, blood pressure differential between selected portions of the stent or graft can be monitored, and blood flow velocities obtained. In alternative embodiments, a plurality of separate implants are placed along a desired target such as a vessel.
- According to a second broad aspect of the invention there is provided a system for monitoring a patient comprising: a medical device according to the first aspect of the invention; and a remote device for receiving data telemetrically transmitted by the telemetric communication means.
- It is highly advantageous that data obtained in vivo, such as from the environs of a heart valve, can be conveniently transmitted to a remote device with little or no inconvenience to the patient. Systems of the present invention can be produced economically, thus facilitating mass manufacture and monitoring of the patient in a wide range of locations such as, for example, a general practitioner's surgery or at the patient's abode. It is a further advantage that the remote device can be a handheld device, thus further facilitating convenient usage. The system does not require the attention of a skilled operative in order to obtain data, and might even be used by the patient himself or herself.
- The remote device may be adapted to provide power remotely to the telemetric communication means. The remote device may be adapted to produce an RF field for this purpose.
- The remote device may comprise memory for storing data transmitted by the telemetric communication means.
- The remote device may comprise data analysis means for performing a physiologically or clinically relevant analysis of data transmitted by the telemetric communication means. An example of data analysis is provided by the instance in which two or more sensors sense blood pressure at different locations in the heart of the patient. In this instance, the remote device (or another component in the system) may calculate a quantity related to the difference in the blood pressures sensed by the two or more sensors. This quantity may be integrated with acoustic or other relevant clinical data, thus aiding enhanced clinical evaluation of the performance of the valve or valve replacement, particularly over time between patient examinations.
- The remote device may comprise data transmission means. The data transmission means may comprise an interface suitable for sending data to the outside world, preferably to a computer. Data may be sent via a network, suitable but non-limiting examples of which are a wide area network (WAN), a local area network (LAN), an intranet, a worldwide computer network, and the Internet.
- The system may further comprise a data storage device which is separate to the remote device, in which the remote device comprises means to write data on the data storage device. The data storage device may be a card having a magnetic data storage area, a digital versatile disc (DVD), a compact disc (CD) or another disc data storage medium. In this way, a record of in vivo data may be built up in a highly convenient manner. The assembled data record on the data storage device might be transported to a skilled physician for analysis and interpretation of the data in order to assess the patient, and/or might be used to assess the performance of the medical device itself. In either instance, the analysis, interpretation or assessment might be performed at a location which is remote from the location at which data were transmitted to the remote device.
- The present invention includes within its scope the provision of one or more intermediate relay devices. In such embodiments, a relay device receives data transmitted by the telemetric communication means and sends the data on to the remote device or another relay device. A relay device may be implanted at a suitable position in the body. Relay devices are of particular importance if the telemetric communication means possesses only a short range.
- According to a third broad aspect of the invention there is provided the use of a medical device according to the first aspect of the invention as an implant in a body for sensing a physiologically or clinically relevant parameter. Uses include in the heart, other organs, vessels, lungs, orthopaedic uses, neurosurgical uses, the urinary system, the digestive system, intensive care monitoring and use with transplanted organs such as the kidneys, liver, or heart, for example, to assess flow and pressure differentials on in-flow and out-flow vessels as a guide to rejection or response to therapy. A preferred but non-limiting embodiment comprises the use of medical devices in the treatment and/or monitoring of an Abdominal Aortic Aneurysm (AAA), in particular in the instance in which the medical device is an AAA graft. Vessels might be arteries, such as the pulmonary artery and the aorta, and veins. Use in intensive care monitoring includes the placement of medical devices of the invention on vessels, such as the pulmonary artery and the aorta in one or more positions, for example, to measure cardiac output and filling pressures at or after open operations such as heart and lung operations. The device may also be used in non-surgical cases where patients have life threatening conditions such as trauma, heart failure or septicaemia. Orthopaedic use includes use on ligaments and joints, for example onto joint capsules or into joint replacement such as hips and knees where stress/strain is an important additional measurement. Neurosurgical use includes measurement of intracranial pressure and intraspinal pressures. Devices of the invention might be placed on the membrane of the brain (dura). Use relating to the lung includes the detection of airway obstruction, particularly in asthma cases, and also measuring the response of asthma cases and other lung conditions to medications. Lung conditions such as emphysema, chronic bronchitis, and other forms of restrictive airway disease might be monitored. Urinary system use includes measurement of bladder pressure, ureteric flow or back flow, and urinary flow. Further uses relate to valve repair and carotic patches following endarterectomy. In the latter instance carotic flows can be measured, and the device can be sewn in place. ECG measurements might be made. Preferred uses of the invention include uses relating to stents and vascular grafts. Vascular grafts may be with or without stents. The medical devices of the invention may themselves comprise the stent or vascular graft itself, or, alternatively, the medical device may be disposed on, in, or in the vicinity of the stent or vascular graft. The medical device may be used to monitor the performance of the stent or vascular graft, for example, by detecting whether leakage or stenosis is occurring, or to assess whether the stent or vascular graft has moved. Non-limiting examples of stents include pulmonary, vascular, coronary, thoracic and abdominal stents. Non-limiting examples of grafts include AAA, infrainguinal, femoral popliteal, femoral distal, vein and vascular access grafts. Examples of vascular access grafts include grafts for patients requiring dialysis and paediatric cardiac conduits. Digestive system measurements may be made, for example, pH and pressure, particularly in the oesophagus, stomach and bowel.
- According to a fourth aspect of the invention there is provided the use of a medical device according to the first aspect of the invention as a heart valve and in sensing a physiologically or clinically relevant parameter.
- According to a fifth aspect of the invention there is provided the use of a medical device according to the first aspect of the invention to assist in the functioning of one of a patient's heart valves and in sensing a physiologically or clinically relevant parameter.
- According to a sixth aspect of the invention there is provided the use of a medical device according to the first aspect of the invention in, on or in the immediate environs of the heart valve of a patient to sense a physiologically or clinical relevant parameter and thereby monitor the functioning of said heart valve.
- Embodiments of medical devices and systems in accordance with the invention will now be described with reference to the accompanying drawings, in which:
-
FIG. 1 is a side view of a stented heart valve in accordance with the invention; -
FIG. 2 is a plan view of the heart valve ofFIG. 1 ; -
FIG. 3 is a cross sectional view of the heart valve ofFIG. 1 , taken along the line the line 3-3 ofFIG. 2 ; -
FIG. 4 is an enlarged view of a portion of the heart valve as shown inFIG. 3 ; -
FIG. 5 is a side view of a freesewn heart valve in accordance with the invention; -
FIG. 6 is a plan view of the heart valve ofFIG. 5 ; -
FIG. 7 is a cross sectional view of the heart valve ofFIG. 5 , taken along the line 7-7 ofFIG. 6 ; -
FIG. 8 is an enlarged view of a portion of the heart valve as shown inFIG. 7 ; -
FIG. 9 shows an arrangement of two sensors and telemetric communication means; -
FIG. 10 shows a system in accordance with the invention; -
FIG. 11 is a cross-sectional view of an AAA graft of the invention installed within a heart; and -
FIG. 12 shows the response of a sensor downstream of porcine tissue heart valve. -
FIGS. 1-4 show a first embodiment of a heart valve 10 according to the invention. The heart valve 10 is a stented tissue valve comprising astent 12 which supports atissue valve wall 14 obtained from a suitable source. Typically, porcine tissue valves are utilised. The tissue valve 10 further comprises avalve 16, thevalve 16 being made up of threetissue leaflets protective cover 18 is provided around the periphery of thevalve wall 14/stent 12. The cover may be produced from any suitable material: typically, a polymeric sheet material such as Dacron® is used, although the invention is not limited in this regard. As shown to best effect inFIG. 4 , the tissue heart valve 10 further comprises afirst sensor 20, asecond sensor 22, and telemetric communication means 24, all of which are disposed in the cavity provided between thevalve wall 14 andstent 12. This location is extremely convenient, since blood flowing through the tissue heart valve 10 is not in direct contact with thesensors sensors valve 16. -
FIGS. 4-8 depict a second embodiment of the present invention which is a free sewn (or stentless)tissue heart valve 30. Thetissue heart valve 30 comprises atissue valve wall 32 and atissue valve 34, thetissue valve 34 itself comprising a plurality of leaflets 34 a, 34 b, 34 c. Again, it is typical that porcine tissue is used to fabricate thetissue heart valve 30, although the invention is not limited in this regard. Thetissue valve 30 further comprises aprotective layer 36, which typically is a crosslinked pericardial cover also obtained from sources of porcine tissue. Thetissue heart valve 30 further comprises afirst sensor 38, asecond sensor 40 and telemetric communication means 42 which are disposed between thevalve wall 32 and thepericardial cover 36. In common with the first embodiment, it is advantageous that the first andsecond sensors valve 34. Additionally, it is highly advantageous that thesensors - Manufacturing techniques and processes such as crosslinking of tissue and suturing of the heart valve structure may be employed in ways well known in the art. The skilled reader will readily appreciate that appropriate suturing can be employed in order to seal the sensors and telemetric communication means in place in between various layers as described above with reference to the first and second embodiments.
- The present invention also relates to stents and vascular grafts having one or more sensors and telemetric communication means. It is advantageous that such devices, having sensing capabilities, can be implanted with a single surgical procedure.
FIG. 11 shows a third embodiment of the invention in which the device is anAAA graft 70 having one or more sensors and telemetric communication means coupled thereto. Typically, an endoscopic procedure is used to position theAAA graft 70 in ananeurysm sac 72. Also shown inFIG. 11 is the main aorta 74. TheAAA graft 70 is a bifurcated structure having amain conduit 70 a and first and second branches 70 b, 70 c. TheAAA graft 70 comprises anextendable structure 70 d disposed at the top end of the graft and an extendable structure 70 e disposed on themain conduit 70 a and first and second branches 70 b, 70 c as is well known in the art. These extendable structures are used to anchor the graft in place. TheAAA graft 70 further comprises one or more extension means 76 on whichsensors 78 and telemetric communication means 80 are disposed. The extension means 76 of the third embodiment operate in much the same manner as the conventional attachment structures used to position vascular grafts and stents, in that the extension means 76 lie substantially flush with thegraft 70 before use, but once in position are caused to extend from the external surface of thegraft 70 by the action of expanding a catheter balloon, or blood flow. It is also possible to dispose the sensors and telemetric communication means on an otherwise conventional extendable structure system, or to dispose them on an external surface of thegraft 70. In another variant, the sensors and telemetric communication means may be disposed on an interior surface of the graft. Positioning of the sensors and telemetric communication means on the exterior of theAAA graft 70 is preferred, however, since it addresses a major problem associated with AAA grafts, namely the problem of measuring pressure inside theaneurysm sac 72, but outside thegraft 70. By the provisional of suitable sensors, such as pressure sensors, it is possible to detect malfunction of the graft or other problems at an early stage. Pressure sensors are particularly useful in this regard, but the invention is not limited to this way. One problem that can be detected is that of leakage into or out of theaneurysm sac 72 and out of thegraft 70. Areas of possible leaks are shown by way of arrows inFIG. 11 . - One or more sensors may be employed in the present invention in order to sense one or more physiologically or clinically relevant parameters. Examples of such parameters include pressure, acoustic signals, temperature and pH. Chemical sensors and biosensors might be used in order to analyse blood flowing through a heart valve. Pressure and acoustic signal measurements are particularly important. Measurement of pressure can provide systolic and diastolic pressure information. Furthermore, it is possible to obtain useful information by examining the differences in pressures measured by two or more pressure sensors. Particularly useful information is obtained when sensors are disposed either side of the valve, such as described above in relation to the first and second embodiments of the invention. In this way, blood flow can be assessed, and leakage across or from the valve can be detected.
- Measurement of pressure difference enables the instantaneous blood flow velocity to be calculated using Bernoulli's equation. Bernoulli's equation incorporates a velocity squared term. In current medical practice, Doppler ultrasound methods are employed to measure velocity by projecting an ultrasound beam as closely as possible to the axis of the aorta. Small angular deviations from the axis result in potentially large inaccuracies in the velocity data, any errors in which are magnified by the dependence of Bernoulli's equation on velocity squared. With the present invention, velocity can be inferred directly from a differential pressure measurement. Thus, the present invention offers the possibility of improved measurement of velocity and hence blood flow or cardiac output.
- By sensing acoustic signals, it is possible to obtain information relating to patterns of heartbeat. For example, it is possible to detect abnormal events, such as heart murmurs.
- It is advantageous to utilise piezoelectric sensors in devices of the present invention, although the invention is not limited in this regard. In preferred embodiments, at least one PVDF based transducer is utilised. An advantage associated with PVDF transducers is that they can be operated as both a pressure transducer and as a microphone, monitoring acoustic signals. In the pressure transducer mode, the PVDF transducer is reacting to blood pressure during the heart cycle. In the microphone mode, the PVDF transducer is listening to the sounds emitted by the blood as it moves through the heart valve. This requires that the PVDF transducer has a band width out to 1 or 2 kHz. Devices of this nature have been described in the literature, but not in the context of heart valves (see, for example, “Tactile Sensors for Robotics in Medicine”, edited by John G Webster, John Wyley, 1988, particularly chapter 8, “Piezoelectric Sensors”, and “The Applications of Ferroelectric Polymers”, Chapman and Hall, 1988, in particular chapter 8, “Microphones, Headphones and Tone Generators”, the contents of both of which are herein incorporated by reference). A piezoelectric material such as PVDF will respond to electric field changes so as to permit ECG measurements to be made. PVDF is inherently a very high electrical impedance material, but in the context of acoustic signals, it is not necessary to use very thin materials. In non-limiting examples, a PVDF thickness of between 60 and 150 μm, preferably between 60 and 110 μm, is used. It is advantageous that it is possible to use relatively large area transducers. Other piezoelectric materials might be used in place of PVDF. In particular, there are numerous polymer based composite materials which could be used. Lead zirconate titantate (PVT) and quartz crystals are examples of other suitable piezoelectric materials which are not polymeric in nature. Miniature quartz crystals can be obtained which have thicknesses around 150 μm and areas of 1 to 2 mm2. Such sensors can be set to resonate in a shear mode, and the resonant frequency is extremely sensitive to outside interferences such as pressure. Thus, pressure changes can be monitored by monitoring changes in self-resonant frequency. In such embodiments, the oscillation of the quartz crystal can be sustained with a form of feedback provided by a small electronic circuit. This operation can be powered using externally applied energy such as RF signals, or by a charged capacitor which can be charged according to methodologies explained elsewhere in this description.
- Other sensors suitable for use in conjunction with the present invention include electrets and sensors comprising particles of carbon suspended in a polymer matrix. An electric microphone might be used to pick up, for example, heart sounds and blood flow sounds. In some cases, a DC bias voltage may be required. Sensors comprising fine particles of carbon suspended in a soft polymer matrix can be used to transduce heart and valve sounds, blood flow sounds, and also pressure signals. It is likely that the thickness of such sensors would be greater then 100 microns, although the invention is not limited in this regard. Transduction can be achieved by making resistance measurements. Energy for interrogation methodologies such as the provision of bias voltages and resistance measurements can be provided using charge stored on a capacitor, preferably a micro-miniature capacitor. The capacitor can be charged according to methodologies explained elsewhere in this description.
- Experiments were performed using acoustic sensors to monitor the action of a number of heart valves. An artificial pumping system for a heart valve was employed together with porcine and mechanical heart valves. Polymer-based sensors (copolymers of PVDF, obtained from Measurement Specialists Inc, USA) were inserted into pockets attached to the valve wall. The sensors were insulated using a polyurethane sheath, and were bathed in high quality mineral transformer oil. A 40 db, 20 kΩ input impedance amplifier was used, and signal displayed using a 1MΩ input into a TDS640A or a 466 storage oscilloscope. Data capture was achieved by a routine in Lab View and data analysis was performed in Lab View or in Origin v6.0. Sensors were positioned on either side of the heart valves, and features were observed which corresponded to the opening (and in some instances the closing) of the heart valves.
FIG. 12 shows signal obtained from a sensor disposed on the downstream side of a porcine tissue heart valve. Data processed using a 50-100 Hz band block filter are shown. A feature can be observed at 20 ms which corresponds to the opening of the valve. A further feature at ca. 85 ms may correspond to the closing of the valve. -
FIG. 9 shows a sensing arrangement comprising twosensors 50, 52 in connection with telemetric communication means 54 throughwiring 56, such as gold wires. Other ways of connecting the sensors to the telemetric communication means would suggest themselves readily to the skilled reader. The function of the telemetric communication means 54 is to telemetrically transmit data related to a parameter sensed by one or more of thesensors 50, 52 to a remote device. It is understood that the medical devices provided by the present invention are intended to be able to transmit data obtained in vivo within a patient who has had the heart valve implanted therein, the data being transmitted out of the body of the patient. The heart valve might be implanted in any of the precise locations in the heart that known heart valves are implanted, using known surgical techniques. - It is anticipated that in practice the data will be directly transmitted from the telemetric communication means to a remote device disposed outside of the body of the patient. However, in principle at least, it may be possible to send data from the telemetric communication means to another device positioned in the body of the patient, e.g., subcutaneously. This device might transmit data (possibly after performing datalogging or data analysis functions) to a further device disposed outside of the body of the patient. In a preferred embodiment, the telemetric communication means 54 is a so-called RF tag device (such devices are also known as radio frequency identification (RFID) chips—see, for example, UK periodical “Computing”, 16 Jan. 2003 edition). Such devices are well known for position monitoring purposes. For example, animals such as cattle and pets may be monitored in this way using a RF tag positioned subcutaneously. RF tag devices are passive devices until interrogated by a suitable, and typically relatively powerful, RF signal. The signal is energetic enough to power up the RF tag device which, in the context of position measurement, typically responds with some form of electronic bar code signal, typically using a response frequency around 450 MHZ. For the purposes of the present invention, the function of the RF tag is altered somewhat from these prior art applications. In particular, the RF tag accepts data from the sensors, and transmits data relating to measurements made by the sensors to the interrogating remote device. One way in which this can be achieved is to use the signal from the sensors to modulate the response from the RF tag in a suitable manner.
- A preferred way in which data is transmitted by the RF tag is by modification of the ID code of the RF tag in response to the data accepted from the sensors. Other methods for transmitting data, such as modulating the data transmission rate of the RF tag, might be contemplated. Suitable powering and data collection regimes would suggest themselves to the skilled person. For example, an RF tag might be powered up at a frequency of 2 Hz and data collected at a frequency of 10 Hz. Further information concerning the operation of RF tags can be found in International Patent Publication WO 02/073523 and U.S. Pat. No. 6,622,567, the contents of both of which are herein incorporated by reference.
- The remote device accepts the data transmitted telemetrically by the RF tag device, and can perform desired functions such as datalogging, data analysis and data presentation. Additionally, the remote device transmits a RF signal to the telemetric communication means in order to power said telemetric communication means. Alternatively, it may be possible to build some or all of the datalogging and data analysis functions into the functionality of the telemetric communication means.
- It is often desirable that the data obtained using the present invention are communicated to a site which is different to the site at which the in vivo measurements were made. For example, for the convenience of the patient, it is desirable to make the in viva measurements at accessible locations such as a general practitioner's surgery or the patient's abode. Equally, it is convenient for a physician or other skilled person who is intended to analyse the data that the data may be conveyed in some way to a location which is convenient for that skilled person. The present invention is highly convenient in this regard, since the remote device can be configured to transmit data over a network such as a WAN, LAN, intranet, worldwide computer network, or the internet. Alternatively, or additionally, the remote device might write the data to a suitable data storage device such as a DVD, a CD or another form of disc storage medium. Very conveniently, the remote device might be configured to write data to a card having a suitable data storage area such as a magnetic data storage area. In this way, the patient can be provided with a “swipe card” on which relevant data can be written. The swipe card can then be conveyed to an interested party for data analysis.
FIG. 10 depicts one embodiment of asystem 60 of the invention comprising aremote device 62 and a heart valve 64. The heart valve 64 has telemetric communication means 66 for telemetrically transmitting data to theremote device 62. It is understood that the heart valve 64 is implanted in the heart of a patient (not shown). Theremote device 62 has aslot 66 through which aswipe card 68 can be translated, thereby permitting data recorded by the heart valve 64 to be stored on theswipe card 68. - There are numerous variations possible which fall within the general ambit of the invention. The first and second embodiments discussed above utilise sensors and telemetric communication means which are, strictly speaking, anchored intravascularly, since these components are disposed inside of the vascular “tree”. It is also possible to dispose these components in an extravascular configuration, or to position them in a strict intravascular sense, i.e., disposed in the blood flow. The sensors and telemetric communication means may be protected by a suitable shell, layer or membrane, or even encapsulated by same. A passive telemetric communication means might be powered by means other than the supply of RF energy. For example, the heart valve might be provided with coils which can be powered up using externally supplied electromagnetic fields other than RF fields. Alternatively still, it may be possible to provide “active” telemetric communication means, rather than a passive one, which is powered internally, allowing continuous or near continuous operation. The sensors may be powered in the same manner. In this case, data from the sensors might be accumulated continuously, rather than on demand when interrogated by the remote device. There are numerous possibilities regarding datalogging and data analysis functions. For example, it may be desirable to only store, process, or notify the existence of data which relate to adverse events. It is possible to provide mechanical heart valves which incorporate in vivo sensing capabilities of the type generally described above. Furthermore, it is possible to “retrofit” to existing heart valves, in order to provide modified existing heart valves so as to provide the in vivo sensing capabilities of the present invention. Another possibility still is to incorporate the sensors and telemetric communication means in a heart valve repair device. Heart valve repair devices are quite commonly used to repair mitral heart valves, although the invention is not limited in this regard. Typically, a support structure, such as a hoop is used, the support structure being sewn into the top of the valve. The hoop may comprise a plastic and may be provided with a cloth cover. It would be possible to dispose the sensor(s) and telemetric communication means within or on such a support structure.
Claims (19)
1-37. (canceled)
38. A system for monitoring a patient comprising:
a medical device adapted to be implanted in a body comprising at least two spaced apart implantable pressure sensors for sensing blood pressure and an implantable RFID device coupled to the implantable pressure sensors for receiving data related to the blood pressures sensed by the implantable pressure sensors in which the medical device is implanted in an extravascular configuration wherein the sensors are out of direct contact with the blood; and
a remote device adapted for positioning exterior of the body for sending a signal to the RFID device to cause the RFID device to telemetrically transmit the data.
39. A system according to claim 38 in which the remote device is adapted to provide power remotely to the RFID device.
40. A system according to claim 38 in which the remote device comprises memory for storing data transmitted by the RFID device.
41. A system according to any of claim 38 in which the remote device comprises data analysis means for performing a physiologically relevant analysis of the data transmitted by the RFID device.
42. A system according to any of claim 38 in which the remote device comprises data transmission means.
43. A system according to any of claim 38 further comprising a data storage device which is separate to the remote device, in which the remote device comprises means to write data on the data storage device.
44. A system according to claim 43 in which the data storage device is a card having a magnetic data storage area, a DVD, a CD or another disc storage medium.
45. A medical device for implantation in a body comprising:
an implantable piezoelectric sensor comprising a polymeric active sensing area which senses blood pressure, the polymeric active sensing area being flexible, the implantable piezoelectric sensor adapted to be implanted in an extravascular configuration wherein the sensors are out of direct contact with the blood; and
an implantable RFID device electrically connected to the sensor for receiving and telemetrically transmitting data related to the blood pressure sensed by the sensor to a remote device exterior of the body in response to the remote device transmitting a signal to the RFID device.
46. A system for monitoring a patient comprising:
a medical device adapted for implantation in a body comprising at least two spaced apart implantable pressure sensors for sensing blood pressure and an implantable RFID device coupled to the implantable pressure sensors for receiving data related to the blood pressures sensed by the implantable pressure sensors in which the medical device is adapted to be implanted in an extravascular configuration wherein the sensors are out of direct contact with the blood;
means for calculating an instantaneous blood velocity from a difference in the blood pressures sensed by the blood pressure sensors using Bernoulli's equations; and
a remote device adapted for positioning exterior of the body for sending a signal to the RFID device to cause the RFID device to telemetrically transmit the data.
47. A medical device according to claim 45 in which the implantable piezoelectric sensor has a thickness ranging from between 60 to 110 microns.
48. A medical device according to claim 45 in which the polymeric active sensing area comprises PVDF.
49. A method for monitoring blood pressure of a patient comprising:
providing an implantable medical device comprising at least two spaced apart implantable pressure sensors for sensing blood pressure within a body, and an implantable telemetric communication means comprising an RFID device coupled to the implantable pressure sensors for telemetrically transmitting data relating to the blood pressures sensed by the pressure sensors to a remote device;
implanting the medical device in the patient's body in an extravascular configuration wherein the sensors are out of direct contact with the blood;
sensing blood pressure within the body using the implanted pressure sensors; and
telemetrically transmitting data related to the blood pressure sensed by the implantable pressures sensors to a remote device.
50. A method according to claim 49 in which the remote device is adapted to provide power remotely to the RFID device.
51. A method according to claim 49 in which the remote device comprises memory for storing the data transmitted by the RFID device.
52. A method according to any of claim 49 in which the remote device comprises data analysis means for performing a physiologically relevant analysis of the data transmitted by the RFID device.
53. A method according to any of claim 49 in which the remote device comprises data transmission means.
54. A method according to any of claim 49 further comprising a data storage device which is separate to the remote device, in which the remote device comprises means to write data on the data storage device.
55. A method according to claim 54 in which the data storage device is a card having a magnetic data storage area, a DVD, a CD or another disc storage medium.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/711,161 US20100217136A1 (en) | 2003-11-04 | 2010-02-23 | Medical devices |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0325679.9 | 2003-11-04 | ||
GB0325679A GB0325679D0 (en) | 2003-11-04 | 2003-11-04 | Medical devices |
US10/718,057 US7416530B2 (en) | 2003-11-04 | 2003-11-20 | Medical devices |
GB0417628A GB0417628D0 (en) | 2004-08-09 | 2004-08-09 | Medical devices |
GB0417628.5 | 2004-08-09 | ||
US10/918,712 US20050165317A1 (en) | 2003-11-04 | 2004-08-13 | Medical devices |
US12/711,161 US20100217136A1 (en) | 2003-11-04 | 2010-02-23 | Medical devices |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/918,712 Continuation US20050165317A1 (en) | 2003-11-04 | 2004-08-13 | Medical devices |
Publications (1)
Publication Number | Publication Date |
---|---|
US20100217136A1 true US20100217136A1 (en) | 2010-08-26 |
Family
ID=34593727
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/718,057 Expired - Fee Related US7416530B2 (en) | 2003-11-04 | 2003-11-20 | Medical devices |
US12/711,161 Abandoned US20100217136A1 (en) | 2003-11-04 | 2010-02-23 | Medical devices |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/718,057 Expired - Fee Related US7416530B2 (en) | 2003-11-04 | 2003-11-20 | Medical devices |
Country Status (3)
Country | Link |
---|---|
US (2) | US7416530B2 (en) |
EP (1) | EP1713380A1 (en) |
WO (1) | WO2005046467A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014013062A1 (en) * | 2012-07-20 | 2014-01-23 | Nassir Navab | Intelligent implanted health sensing device and assembly |
WO2014144070A1 (en) * | 2013-03-15 | 2014-09-18 | Hunter William L | Stent monitoring assembly and method of use thereof |
US8870791B2 (en) | 2006-03-23 | 2014-10-28 | Michael E. Sabatino | Apparatus for acquiring, processing and transmitting physiological sounds |
CN109222917A (en) * | 2017-07-10 | 2019-01-18 | 中国科学院微电子研究所 | Pulse wave sensor, sensor array and pulse wave measurement method |
US10499855B2 (en) | 2012-12-21 | 2019-12-10 | Canary Medical Inc. | Stent graft monitoring assembly and method of use thereof |
US10524694B2 (en) | 2014-06-25 | 2020-01-07 | Canaray Medical Inc. | Devices, systems and methods for using and monitoring tubes in body passageways |
US11452497B2 (en) | 2020-05-19 | 2022-09-27 | Coravie Medical, Inc. | Injectable hemodynamic monitoring devices, systems and methods |
Families Citing this family (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6602286B1 (en) | 2000-10-26 | 2003-08-05 | Ernst Peter Strecker | Implantable valve system |
US6752828B2 (en) | 2002-04-03 | 2004-06-22 | Scimed Life Systems, Inc. | Artificial valve |
US6945957B2 (en) | 2002-12-30 | 2005-09-20 | Scimed Life Systems, Inc. | Valve treatment catheter and methods |
US20050165317A1 (en) * | 2003-11-04 | 2005-07-28 | Turner Nicholas M. | Medical devices |
US7416530B2 (en) * | 2003-11-04 | 2008-08-26 | L & P 100 Limited | Medical devices |
US7854761B2 (en) | 2003-12-19 | 2010-12-21 | Boston Scientific Scimed, Inc. | Methods for venous valve replacement with a catheter |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7566343B2 (en) | 2004-09-02 | 2009-07-28 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US7585280B2 (en) | 2004-12-29 | 2009-09-08 | Codman & Shurtleff, Inc. | System and method for measuring the pressure of a fluid system within a patient |
US7775966B2 (en) | 2005-02-24 | 2010-08-17 | Ethicon Endo-Surgery, Inc. | Non-invasive pressure measurement in a fluid adjustable restrictive device |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
US7854755B2 (en) | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
US20060173490A1 (en) | 2005-02-01 | 2006-08-03 | Boston Scientific Scimed, Inc. | Filter system and method |
US7878966B2 (en) | 2005-02-04 | 2011-02-01 | Boston Scientific Scimed, Inc. | Ventricular assist and support device |
US7780722B2 (en) | 2005-02-07 | 2010-08-24 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7670368B2 (en) | 2005-02-07 | 2010-03-02 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7545272B2 (en) | 2005-02-08 | 2009-06-09 | Therasense, Inc. | RF tag on test strips, test strip vials and boxes |
US7867274B2 (en) | 2005-02-23 | 2011-01-11 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US7927270B2 (en) | 2005-02-24 | 2011-04-19 | Ethicon Endo-Surgery, Inc. | External mechanical pressure sensor for gastric band pressure measurements |
US7658196B2 (en) | 2005-02-24 | 2010-02-09 | Ethicon Endo-Surgery, Inc. | System and method for determining implanted device orientation |
US7699770B2 (en) | 2005-02-24 | 2010-04-20 | Ethicon Endo-Surgery, Inc. | Device for non-invasive measurement of fluid pressure in an adjustable restriction device |
US8066629B2 (en) | 2005-02-24 | 2011-11-29 | Ethicon Endo-Surgery, Inc. | Apparatus for adjustment and sensing of gastric band pressure |
US8016744B2 (en) | 2005-02-24 | 2011-09-13 | Ethicon Endo-Surgery, Inc. | External pressure-based gastric band adjustment system and method |
US7775215B2 (en) | 2005-02-24 | 2010-08-17 | Ethicon Endo-Surgery, Inc. | System and method for determining implanted device positioning and obtaining pressure data |
US7722666B2 (en) | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US7474223B2 (en) | 2005-04-18 | 2009-01-06 | Warsaw Orthopedic, Inc. | Method and apparatus for implant identification |
US8012198B2 (en) | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US7569071B2 (en) | 2005-09-21 | 2009-08-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US7682313B2 (en) | 2005-11-23 | 2010-03-23 | Vital Sensors Holding Company, Inc. | Implantable pressure monitor |
US7686768B2 (en) * | 2005-11-23 | 2010-03-30 | Vital Sensors Holding Company, Inc. | Implantable pressure monitor |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US7799038B2 (en) | 2006-01-20 | 2010-09-21 | Boston Scientific Scimed, Inc. | Translumenal apparatus, system, and method |
US8870742B2 (en) | 2006-04-06 | 2014-10-28 | Ethicon Endo-Surgery, Inc. | GUI for an implantable restriction device and a data logger |
US8152710B2 (en) | 2006-04-06 | 2012-04-10 | Ethicon Endo-Surgery, Inc. | Physiological parameter analysis for an implantable restriction device and a data logger |
AR060952A1 (en) * | 2006-05-18 | 2008-07-23 | Med El Elektromed Geraete Gmbh | IMPLANTABLE MICROPHONE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |
US9101264B2 (en) | 2006-06-15 | 2015-08-11 | Peerbridge Health, Inc. | Wireless electrode arrangement and method for patient monitoring via electrocardiography |
US7979111B2 (en) * | 2006-06-15 | 2011-07-12 | Angelo Joseph Acquista | Wireless electrode arrangement and method for patient monitoring via electrocardiography |
ES2312256B1 (en) * | 2006-06-30 | 2009-12-22 | Universidad Complutense De Madrid | MAGNETIC SENSOR DETECTION OF THE DETERIORATION OF CARDIAC PROTESIS AND METHOD OF DETECTION. |
US7643879B2 (en) * | 2006-08-24 | 2010-01-05 | Cardiac Pacemakers, Inc. | Integrated cardiac rhythm management system with heart valve |
DE102006049378A1 (en) * | 2006-10-19 | 2008-04-24 | Siemens Ag | Implant i.e. electrical passive implant, jointing knee of patient, has passive radio frequency identification unit coupled with deformation sensors, for monitoring sensor value, where sensors are implemented as servicing interface |
WO2008091493A1 (en) | 2007-01-08 | 2008-07-31 | California Institute Of Technology | In-situ formation of a valve |
EP2109417B1 (en) | 2007-02-05 | 2013-11-06 | Boston Scientific Limited | Percutaneous valve and delivery system |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US7901360B1 (en) * | 2007-05-17 | 2011-03-08 | Pacesetter, Inc. | Implantable sensor for measuring physiologic information |
EP1994912B1 (en) * | 2007-05-21 | 2010-03-03 | Berardino Della Sala | Electromagnetically closable non-return valve for biological liquid pumps |
US8828079B2 (en) | 2007-07-26 | 2014-09-09 | Boston Scientific Scimed, Inc. | Circulatory valve, system and method |
US7747302B2 (en) | 2007-08-08 | 2010-06-29 | Lifescan, Inc. | Method for integrating facilitated blood flow and blood analyte monitoring |
EP3492043A3 (en) | 2007-08-21 | 2019-09-04 | Symetis SA | A replacement valve |
KR100899393B1 (en) * | 2007-09-07 | 2009-05-27 | 주식회사 하이닉스반도체 | Method for fabricating isolation layer in semiconductor device |
US7755488B2 (en) * | 2007-09-21 | 2010-07-13 | Baxter International Inc. | Access disconnection detection system |
CA2703665C (en) | 2007-10-25 | 2016-05-10 | Symetis Sa | Stents, valved-stents and methods and systems for delivery thereof |
US8454524B2 (en) | 2007-10-31 | 2013-06-04 | DePuy Synthes Products, LLC | Wireless flow sensor |
US8480612B2 (en) | 2007-10-31 | 2013-07-09 | DePuy Synthes Products, LLC | Wireless shunts with storage |
US7842004B2 (en) | 2007-10-31 | 2010-11-30 | Codman & Shurtleff, Inc. | Wireless pressure setting indicator |
US9204812B2 (en) | 2007-10-31 | 2015-12-08 | DePuy Synthes Products, LLC | Wireless pressure sensing shunts |
AU2014203011B2 (en) * | 2007-10-31 | 2015-12-17 | Integra LifeSciences Switzerland Sarl | Wireless shunts with storage |
US8187163B2 (en) | 2007-12-10 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Methods for implanting a gastric restriction device |
US8100870B2 (en) | 2007-12-14 | 2012-01-24 | Ethicon Endo-Surgery, Inc. | Adjustable height gastric restriction devices and methods |
US7892276B2 (en) | 2007-12-21 | 2011-02-22 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US8377079B2 (en) | 2007-12-27 | 2013-02-19 | Ethicon Endo-Surgery, Inc. | Constant force mechanisms for regulating restriction devices |
US8142452B2 (en) | 2007-12-27 | 2012-03-27 | Ethicon Endo-Surgery, Inc. | Controlling pressure in adjustable restriction devices |
US8591395B2 (en) | 2008-01-28 | 2013-11-26 | Ethicon Endo-Surgery, Inc. | Gastric restriction device data handling devices and methods |
US8337389B2 (en) * | 2008-01-28 | 2012-12-25 | Ethicon Endo-Surgery, Inc. | Methods and devices for diagnosing performance of a gastric restriction system |
US8192350B2 (en) | 2008-01-28 | 2012-06-05 | Ethicon Endo-Surgery, Inc. | Methods and devices for measuring impedance in a gastric restriction system |
US8221439B2 (en) | 2008-02-07 | 2012-07-17 | Ethicon Endo-Surgery, Inc. | Powering implantable restriction systems using kinetic motion |
US7844342B2 (en) | 2008-02-07 | 2010-11-30 | Ethicon Endo-Surgery, Inc. | Powering implantable restriction systems using light |
US8114345B2 (en) | 2008-02-08 | 2012-02-14 | Ethicon Endo-Surgery, Inc. | System and method of sterilizing an implantable medical device |
US8057492B2 (en) | 2008-02-12 | 2011-11-15 | Ethicon Endo-Surgery, Inc. | Automatically adjusting band system with MEMS pump |
US8591532B2 (en) | 2008-02-12 | 2013-11-26 | Ethicon Endo-Sugery, Inc. | Automatically adjusting band system |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
US8034065B2 (en) | 2008-02-26 | 2011-10-11 | Ethicon Endo-Surgery, Inc. | Controlling pressure in adjustable restriction devices |
ES2903231T3 (en) | 2008-02-26 | 2022-03-31 | Jenavalve Tech Inc | Stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart |
US8233995B2 (en) | 2008-03-06 | 2012-07-31 | Ethicon Endo-Surgery, Inc. | System and method of aligning an implantable antenna |
US8187162B2 (en) | 2008-03-06 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Reorientation port |
US10194802B2 (en) | 2009-06-11 | 2019-02-05 | Ao Technology Ag | Device for processing and transmitting measured signals for monitoring and/or controlling medical implants, diagnostic devices or biological processes |
CA2778944C (en) | 2009-11-02 | 2019-08-20 | Symetis Sa | Aortic bioprosthesis and systems for delivery thereof |
ITRM20100153A1 (en) * | 2010-04-02 | 2011-10-03 | Uni Degli Studi Di Roma To R Vergata | IMPLANTABLE DEVICE IN BIOLOGICAL DUCTS |
JP2013526388A (en) | 2010-05-25 | 2013-06-24 | イエナバルブ テクノロジー インク | Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent |
US20120123284A1 (en) * | 2010-11-17 | 2012-05-17 | Arash Kheradvar | Wireless hemodynamic monitoring system integrated with implantable heart valves |
US8641610B2 (en) | 2010-12-20 | 2014-02-04 | Covidien Lp | Access assembly with translating lumens |
US8602983B2 (en) | 2010-12-20 | 2013-12-10 | Covidien Lp | Access assembly having undercut structure |
US8696557B2 (en) | 2010-12-21 | 2014-04-15 | Covidien Lp | Access assembly including inflatable seal member |
US9649113B2 (en) | 2011-04-27 | 2017-05-16 | Covidien Lp | Device for monitoring physiological parameters in vivo |
US8945209B2 (en) | 2011-05-20 | 2015-02-03 | Edwards Lifesciences Corporation | Encapsulated heart valve |
US10022054B2 (en) | 2011-06-08 | 2018-07-17 | Integrated Sensing Systems, Inc. | Implantable wireless sensor systems |
US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
US20140379090A1 (en) | 2011-08-08 | 2014-12-25 | Ecole Polytechnique Federale De Lausanne (Epfl) | In-vivo condition monitoring of metallic implants by electrochemical techniques |
US11207176B2 (en) | 2012-03-22 | 2021-12-28 | Boston Scientific Scimed, Inc. | Transcatheter stent-valves and methods, systems and devices for addressing para-valve leakage |
US20130274873A1 (en) | 2012-03-22 | 2013-10-17 | Symetis Sa | Transcatheter Stent-Valves and Methods, Systems and Devices for Addressing Para-Valve Leakage |
US20140107505A1 (en) | 2012-10-11 | 2014-04-17 | Alon Marmor | Determination of ventricular pressure and related values |
US9744037B2 (en) | 2013-03-15 | 2017-08-29 | California Institute Of Technology | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
WO2014190185A1 (en) | 2013-05-22 | 2014-11-27 | Covidien Lp | Methods and apparatus for controlling surgical instruments using a port assembly |
US9427592B2 (en) | 2013-08-28 | 2016-08-30 | Pacesetter, Inc. | Systems and methods for low energy wake-up and pairing for use with implantable medical devices |
JP6563394B2 (en) | 2013-08-30 | 2019-08-21 | イェーナヴァルヴ テクノロジー インコーポレイテッド | Radially foldable frame for an artificial valve and method for manufacturing the frame |
WO2015200707A1 (en) * | 2014-06-25 | 2015-12-30 | Hunter William L | Devices, systems and methods for using and monitoring heart valves |
WO2016100806A1 (en) * | 2014-12-18 | 2016-06-23 | Medtronic Inc. | Transcatheter prosthetic heart valve delivery system with clinician feedback |
US10709555B2 (en) | 2015-05-01 | 2020-07-14 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
US10080653B2 (en) | 2015-09-10 | 2018-09-25 | Edwards Lifesciences Corporation | Limited expansion heart valve |
US10667904B2 (en) | 2016-03-08 | 2020-06-02 | Edwards Lifesciences Corporation | Valve implant with integrated sensor and transmitter |
EP3454795B1 (en) | 2016-05-13 | 2023-01-11 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system for delivery of heart valve prosthesis with introducer sheath and loading system |
US10989788B2 (en) * | 2016-11-17 | 2021-04-27 | Lion Group, Inc. | Radio frequency identification (RFID) system for determining location |
JP7094965B2 (en) | 2017-01-27 | 2022-07-04 | イエナバルブ テクノロジー インク | Heart valve imitation |
US10463485B2 (en) | 2017-04-06 | 2019-11-05 | Edwards Lifesciences Corporation | Prosthetic valve holders with automatic deploying mechanisms |
EP3614969B1 (en) | 2017-04-28 | 2023-05-03 | Edwards Lifesciences Corporation | Prosthetic heart valve with collapsible holder |
EP3641700A4 (en) | 2017-06-21 | 2020-08-05 | Edwards Lifesciences Corporation | Dual-wireform limited expansion heart valves |
CN114641263A (en) | 2019-12-16 | 2022-06-17 | 爱德华兹生命科学公司 | Valve holder assembly with suture looping protection |
US11883028B2 (en) | 2021-09-08 | 2024-01-30 | Covidien Lp | Systems and methods for post-operative anastomotic leak detection |
Citations (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4067703A (en) * | 1973-04-26 | 1978-01-10 | Dullien Francis A L | Gas scrubber and method of operation |
US4600855A (en) * | 1983-09-28 | 1986-07-15 | Medex, Inc. | Piezoelectric apparatus for measuring bodily fluid pressure within a conduit |
US4706143A (en) * | 1982-09-30 | 1987-11-10 | Matsushita Electric Industrial Co., Ltd. | Rotary head cylinder device with fluid bearing |
US4798206A (en) * | 1986-10-28 | 1989-01-17 | Telectronics N.V. | Implanted medical system including a self-powered sensing system |
US5032128A (en) * | 1988-07-07 | 1991-07-16 | Medtronic, Inc. | Heart valve prosthesis |
US5156621A (en) * | 1988-03-22 | 1992-10-20 | Navia Jose A | Stentless bioprosthetic cardiac valve |
US5411551A (en) * | 1992-08-05 | 1995-05-02 | Ultrasonic Sensing And Monitoring Systems, Inc. | Stent assembly with sensor |
US5427112A (en) * | 1992-12-18 | 1995-06-27 | Siemens Elema Ab | Device for analyzing the function of a heart |
US5487760A (en) * | 1994-03-08 | 1996-01-30 | Ats Medical, Inc. | Heart valve prosthesis incorporating electronic sensing, monitoring and/or pacing circuitry |
US5553503A (en) * | 1994-10-11 | 1996-09-10 | Manometrx Group Ltd | Measurement of fluid pressure such as blood pressure |
US5855550A (en) * | 1996-11-13 | 1999-01-05 | Lai; Joseph | Method and system for remotely monitoring multiple medical parameters |
US5967986A (en) * | 1997-11-25 | 1999-10-19 | Vascusense, Inc. | Endoluminal implant with fluid flow sensing capability |
US6053873A (en) * | 1997-01-03 | 2000-04-25 | Biosense, Inc. | Pressure-sensing stent |
US6171253B1 (en) * | 1999-05-04 | 2001-01-09 | Apex Medical, Inc. | Flat tube pressure sensor |
US6277078B1 (en) * | 1999-11-19 | 2001-08-21 | Remon Medical Technologies, Ltd. | System and method for monitoring a parameter associated with the performance of a heart |
US20020072656A1 (en) * | 1999-05-03 | 2002-06-13 | Tricardia, L.L.C. | Pressure/temperature/flow monitor device for vascular implantation |
US6409675B1 (en) * | 1999-11-10 | 2002-06-25 | Pacesetter, Inc. | Extravascular hemodynamic monitor |
US20020120200A1 (en) * | 1997-10-14 | 2002-08-29 | Brian Brockway | Devices, systems and methods for endocardial pressure measurement |
US20020151816A1 (en) * | 2001-01-22 | 2002-10-17 | Rich Collin A. | Wireless MEMS capacitive sensor for physiologic parameter measurement |
US6486588B2 (en) * | 1997-12-30 | 2002-11-26 | Remon Medical Technologies Ltd | Acoustic biosensor for monitoring physiological conditions in a body implantation site |
US20030004411A1 (en) * | 1999-03-11 | 2003-01-02 | Assaf Govari | Invasive medical device with position sensing and display |
US20030032993A1 (en) * | 1998-12-22 | 2003-02-13 | Marlin Mickle | Apparatus for energizing a remote station and related method |
US20030120159A1 (en) * | 1996-12-18 | 2003-06-26 | Mohler Sailor H. | System and method of detecting and processing physiological sounds |
US6592518B2 (en) * | 2001-04-05 | 2003-07-15 | Kenergy, Inc. | Cardiac monitoring system and method with multiple implanted transponders |
US20030139677A1 (en) * | 2002-01-22 | 2003-07-24 | Michael Fonseca | Implantable wireless sensor for pressure measurement within the heart |
US20030136417A1 (en) * | 2002-01-22 | 2003-07-24 | Michael Fonseca | Implantable wireless sensor |
US6622567B1 (en) * | 1999-03-01 | 2003-09-23 | Microstrain, Inc. | Micropower peak strain detection system for remote interrogation |
US20030195497A1 (en) * | 1999-04-28 | 2003-10-16 | St. Jude Medical, Inc. | Aortic heart value prosthesis sizer and marker |
US6638231B2 (en) * | 2000-12-18 | 2003-10-28 | Biosense, Inc. | Implantable telemetric medical sensor and method |
US6658300B2 (en) * | 2000-12-18 | 2003-12-02 | Biosense, Inc. | Telemetric reader/charger device for medical sensor |
US6667725B1 (en) * | 2002-08-20 | 2003-12-23 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Radio frequency telemetry system for sensors and actuators |
US6729336B2 (en) * | 2001-11-27 | 2004-05-04 | Pearl Technology Holdings, Llc | In-stent restenosis detection device |
US20040085427A1 (en) * | 2002-10-31 | 2004-05-06 | Samsung Electronics Co., Ltd | Paper guide for an ink-jet printer and ink-jet printer having the same |
US6743180B1 (en) * | 1997-08-15 | 2004-06-01 | Rijksuniversiteit Leiden | Pressure sensor for use in an artery |
US6918873B1 (en) * | 2002-09-19 | 2005-07-19 | Millar Instruments, Inc. | Inverted sensor module |
US20050247319A1 (en) * | 2004-05-07 | 2005-11-10 | Berger J L | Medical implant device with RFID tag and method of identification of device |
US7015826B1 (en) * | 2002-04-02 | 2006-03-21 | Digital Angel Corporation | Method and apparatus for sensing and transmitting a body characteristic of a host |
US7024244B2 (en) * | 2002-04-22 | 2006-04-04 | Medtronic, Inc. | Estimation of stroke volume cardiac output using an intracardiac pressure sensor |
US7026941B1 (en) * | 2001-03-01 | 2006-04-11 | Netquest Services, Llc | System and method for measuring a plurality of physical variables from a remote location |
US7256695B2 (en) * | 2002-09-23 | 2007-08-14 | Microstrain, Inc. | Remotely powered and remotely interrogated wireless digital sensor telemetry system |
US7416530B2 (en) * | 2003-11-04 | 2008-08-26 | L & P 100 Limited | Medical devices |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3671979A (en) * | 1969-09-23 | 1972-06-27 | Univ Utah | Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve |
US4979955A (en) * | 1988-06-06 | 1990-12-25 | Smith Robert M | Power assisted prosthetic heart valve |
EP0758542B1 (en) | 1995-08-16 | 2003-03-12 | Manuel A. Villafana | Heart valve prosthesis incorporating electronic monitoring and/or pacing circuitry |
US6331163B1 (en) * | 1998-01-08 | 2001-12-18 | Microsense Cardiovascular Systems (1196) Ltd. | Protective coating for bodily sensor |
US6638303B1 (en) * | 1998-03-13 | 2003-10-28 | Carbomedics, Inc. | Heart valve prosthesis |
US8636648B2 (en) * | 1999-03-01 | 2014-01-28 | West View Research, Llc | Endoscopic smart probe |
GB2352931A (en) | 1999-07-29 | 2001-02-07 | Marconi Electronic Syst Ltd | Piezoelectric tag |
GB0008883D0 (en) * | 2000-04-12 | 2000-05-31 | Univ Ulster | Bodily flow measuring system |
US20040133092A1 (en) | 2001-03-27 | 2004-07-08 | Kain Aron Z. | Wireless system for measuring distension in flexible tubes |
WO2002098296A1 (en) * | 2001-06-05 | 2002-12-12 | Apex Medical, Inc. | Pressure sensing endograft |
US6915157B2 (en) | 2003-02-18 | 2005-07-05 | Medtronic, Inc. | Implantable medical device for assessing heart failure state from Mechanical Pulsus Alternans |
-
2003
- 2003-11-20 US US10/718,057 patent/US7416530B2/en not_active Expired - Fee Related
-
2004
- 2004-11-04 WO PCT/GB2004/004661 patent/WO2005046467A1/en active Application Filing
- 2004-11-04 EP EP04798387A patent/EP1713380A1/en not_active Withdrawn
-
2010
- 2010-02-23 US US12/711,161 patent/US20100217136A1/en not_active Abandoned
Patent Citations (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4067703A (en) * | 1973-04-26 | 1978-01-10 | Dullien Francis A L | Gas scrubber and method of operation |
US4706143A (en) * | 1982-09-30 | 1987-11-10 | Matsushita Electric Industrial Co., Ltd. | Rotary head cylinder device with fluid bearing |
US4600855A (en) * | 1983-09-28 | 1986-07-15 | Medex, Inc. | Piezoelectric apparatus for measuring bodily fluid pressure within a conduit |
US4798206A (en) * | 1986-10-28 | 1989-01-17 | Telectronics N.V. | Implanted medical system including a self-powered sensing system |
US5156621A (en) * | 1988-03-22 | 1992-10-20 | Navia Jose A | Stentless bioprosthetic cardiac valve |
US5032128A (en) * | 1988-07-07 | 1991-07-16 | Medtronic, Inc. | Heart valve prosthesis |
US5411551A (en) * | 1992-08-05 | 1995-05-02 | Ultrasonic Sensing And Monitoring Systems, Inc. | Stent assembly with sensor |
US5427112A (en) * | 1992-12-18 | 1995-06-27 | Siemens Elema Ab | Device for analyzing the function of a heart |
US5487760A (en) * | 1994-03-08 | 1996-01-30 | Ats Medical, Inc. | Heart valve prosthesis incorporating electronic sensing, monitoring and/or pacing circuitry |
US5553503A (en) * | 1994-10-11 | 1996-09-10 | Manometrx Group Ltd | Measurement of fluid pressure such as blood pressure |
US5855550A (en) * | 1996-11-13 | 1999-01-05 | Lai; Joseph | Method and system for remotely monitoring multiple medical parameters |
US20030120159A1 (en) * | 1996-12-18 | 2003-06-26 | Mohler Sailor H. | System and method of detecting and processing physiological sounds |
US6053873A (en) * | 1997-01-03 | 2000-04-25 | Biosense, Inc. | Pressure-sensing stent |
US6743180B1 (en) * | 1997-08-15 | 2004-06-01 | Rijksuniversiteit Leiden | Pressure sensor for use in an artery |
US20020120200A1 (en) * | 1997-10-14 | 2002-08-29 | Brian Brockway | Devices, systems and methods for endocardial pressure measurement |
US5967986A (en) * | 1997-11-25 | 1999-10-19 | Vascusense, Inc. | Endoluminal implant with fluid flow sensing capability |
US6486588B2 (en) * | 1997-12-30 | 2002-11-26 | Remon Medical Technologies Ltd | Acoustic biosensor for monitoring physiological conditions in a body implantation site |
US20030032993A1 (en) * | 1998-12-22 | 2003-02-13 | Marlin Mickle | Apparatus for energizing a remote station and related method |
US6622567B1 (en) * | 1999-03-01 | 2003-09-23 | Microstrain, Inc. | Micropower peak strain detection system for remote interrogation |
US20030004411A1 (en) * | 1999-03-11 | 2003-01-02 | Assaf Govari | Invasive medical device with position sensing and display |
US20030195497A1 (en) * | 1999-04-28 | 2003-10-16 | St. Jude Medical, Inc. | Aortic heart value prosthesis sizer and marker |
US20020072656A1 (en) * | 1999-05-03 | 2002-06-13 | Tricardia, L.L.C. | Pressure/temperature/flow monitor device for vascular implantation |
US6645143B2 (en) * | 1999-05-03 | 2003-11-11 | Tricardia, L.L.C. | Pressure/temperature/flow monitor device for vascular implantation |
US6171253B1 (en) * | 1999-05-04 | 2001-01-09 | Apex Medical, Inc. | Flat tube pressure sensor |
US6409675B1 (en) * | 1999-11-10 | 2002-06-25 | Pacesetter, Inc. | Extravascular hemodynamic monitor |
US6277078B1 (en) * | 1999-11-19 | 2001-08-21 | Remon Medical Technologies, Ltd. | System and method for monitoring a parameter associated with the performance of a heart |
US6638231B2 (en) * | 2000-12-18 | 2003-10-28 | Biosense, Inc. | Implantable telemetric medical sensor and method |
US6658300B2 (en) * | 2000-12-18 | 2003-12-02 | Biosense, Inc. | Telemetric reader/charger device for medical sensor |
US20020151816A1 (en) * | 2001-01-22 | 2002-10-17 | Rich Collin A. | Wireless MEMS capacitive sensor for physiologic parameter measurement |
US7026941B1 (en) * | 2001-03-01 | 2006-04-11 | Netquest Services, Llc | System and method for measuring a plurality of physical variables from a remote location |
US6592518B2 (en) * | 2001-04-05 | 2003-07-15 | Kenergy, Inc. | Cardiac monitoring system and method with multiple implanted transponders |
US6729336B2 (en) * | 2001-11-27 | 2004-05-04 | Pearl Technology Holdings, Llc | In-stent restenosis detection device |
US20030136417A1 (en) * | 2002-01-22 | 2003-07-24 | Michael Fonseca | Implantable wireless sensor |
US20030139677A1 (en) * | 2002-01-22 | 2003-07-24 | Michael Fonseca | Implantable wireless sensor for pressure measurement within the heart |
US7015826B1 (en) * | 2002-04-02 | 2006-03-21 | Digital Angel Corporation | Method and apparatus for sensing and transmitting a body characteristic of a host |
US7024244B2 (en) * | 2002-04-22 | 2006-04-04 | Medtronic, Inc. | Estimation of stroke volume cardiac output using an intracardiac pressure sensor |
US6667725B1 (en) * | 2002-08-20 | 2003-12-23 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Radio frequency telemetry system for sensors and actuators |
US6918873B1 (en) * | 2002-09-19 | 2005-07-19 | Millar Instruments, Inc. | Inverted sensor module |
US7256695B2 (en) * | 2002-09-23 | 2007-08-14 | Microstrain, Inc. | Remotely powered and remotely interrogated wireless digital sensor telemetry system |
US20040085427A1 (en) * | 2002-10-31 | 2004-05-06 | Samsung Electronics Co., Ltd | Paper guide for an ink-jet printer and ink-jet printer having the same |
US7416530B2 (en) * | 2003-11-04 | 2008-08-26 | L & P 100 Limited | Medical devices |
US20050247319A1 (en) * | 2004-05-07 | 2005-11-10 | Berger J L | Medical implant device with RFID tag and method of identification of device |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11357471B2 (en) | 2006-03-23 | 2022-06-14 | Michael E. Sabatino | Acquiring and processing acoustic energy emitted by at least one organ in a biological system |
US8870791B2 (en) | 2006-03-23 | 2014-10-28 | Michael E. Sabatino | Apparatus for acquiring, processing and transmitting physiological sounds |
US8920343B2 (en) | 2006-03-23 | 2014-12-30 | Michael Edward Sabatino | Apparatus for acquiring and processing of physiological auditory signals |
WO2014013062A1 (en) * | 2012-07-20 | 2014-01-23 | Nassir Navab | Intelligent implanted health sensing device and assembly |
US11445978B2 (en) | 2012-12-21 | 2022-09-20 | Canary Medical Switzerland Ag | Stent graft monitoring assembly and method of use thereof |
US10499855B2 (en) | 2012-12-21 | 2019-12-10 | Canary Medical Inc. | Stent graft monitoring assembly and method of use thereof |
WO2014144070A1 (en) * | 2013-03-15 | 2014-09-18 | Hunter William L | Stent monitoring assembly and method of use thereof |
EP3988061A1 (en) * | 2013-03-15 | 2022-04-27 | Canary Medical Inc. | Stent monitoring assembly and method of use thereof |
US10524694B2 (en) | 2014-06-25 | 2020-01-07 | Canaray Medical Inc. | Devices, systems and methods for using and monitoring tubes in body passageways |
US11389079B2 (en) | 2014-06-25 | 2022-07-19 | Canary Medical Inc. | Devices, systems and methods for using and monitoring tubes in body passageways |
US11911141B2 (en) | 2014-06-25 | 2024-02-27 | Canary Medical Switzerland Ag | Devices, systems and methods for using and monitoring tubes in body passageways |
CN109222917A (en) * | 2017-07-10 | 2019-01-18 | 中国科学院微电子研究所 | Pulse wave sensor, sensor array and pulse wave measurement method |
US11452497B2 (en) | 2020-05-19 | 2022-09-27 | Coravie Medical, Inc. | Injectable hemodynamic monitoring devices, systems and methods |
US11826195B2 (en) | 2020-05-19 | 2023-11-28 | Coravie Medical, Inc. | Subcutaneous hemodynamic monitoring devices, systems and methods |
Also Published As
Publication number | Publication date |
---|---|
EP1713380A1 (en) | 2006-10-25 |
US7416530B2 (en) | 2008-08-26 |
WO2005046467A1 (en) | 2005-05-26 |
US20050102026A1 (en) | 2005-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20100217136A1 (en) | Medical devices | |
US20050165317A1 (en) | Medical devices | |
US11547352B2 (en) | Method and apparatus for measuring flow through a lumen | |
JP6991988B2 (en) | Valve implant with integrated sensor and transmitter | |
US20080058652A1 (en) | Medical Devices | |
US20150320357A1 (en) | Methods for assessing fluid flow through a conduit | |
JP2022518028A (en) | Implantable joining support equipment with sensors and related systems and methods | |
US9924905B2 (en) | Sensor position on a prosthesis for detection of a stenosis | |
US20160256107A1 (en) | Detection of stenosis in a prosthesis using break frequency |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: L & P 100 LIMITED, UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PAYNE, PETER ALFRED;DAVIES, G. ALBAN;DAVIES, JULIE;SIGNING DATES FROM 20041214 TO 20041220;REEL/FRAME:023979/0797 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |